beta-Amyloid	B-protein
fibrils	I-protein
activate	O
parallel	O
mitogen-activated	B-protein
protein	I-protein
kinase	I-protein
pathways	O
in	O
microglia	B-cell_type
and	O
THP1	B-cell_line
monocytes	I-cell_line
.	O

The	O
senile	O
plaques	O
of	O
Alzheimer	O
's	O
disease	O
are	O
foci	O
of	O
local	O
inflammatory	O
responses	O
,	O
as	O
evidenced	O
by	O
the	O
presence	O
of	O
acute	B-protein
phase	I-protein
proteins	I-protein
and	O
oxidative	O
damage	O
.	O

Fibrillar	B-protein
forms	I-protein
of	O
beta-amyloid	B-protein
(	O
Abeta	B-protein
)	O
,	O
which	O
are	O
the	O
primary	O
constituents	O
of	O
senile	O
plaques	O
,	O
have	O
been	O
shown	O
to	O
activate	O
tyrosine	O
kinase-dependent	O
signal	O
transduction	O
cascades	O
,	O
resulting	O
in	O
inflammatory	O
responses	O
in	O
microglia	B-cell_type
.	O

However	O
,	O
the	O
downstream	O
signaling	O
pathways	O
mediating	O
Abeta	B-protein
-induced	O
inflammatory	O
events	O
are	O
not	O
well	O
characterized	O
.	O

We	O
report	O
that	O
exposure	O
of	O
primary	B-cell_type
rat	I-cell_type
microglia	I-cell_type
and	O
human	B-cell_line
THP1	I-cell_line
monocytes	I-cell_line
to	O
fibrillar	B-protein
Abeta	I-protein
results	O
in	O
the	O
tyrosine	B-protein
kinase	I-protein
-dependent	O
activation	O
of	O
two	O
parallel	O
signal	O
transduction	O
cascades	O
involving	O
members	O
of	O
the	O
mitogen-activated	B-protein
protein	I-protein
kinase	I-protein
(	I-protein
MAPK	I-protein
)	I-protein
superfamily	I-protein
.	O

Abeta	B-protein
stimulated	O
the	O
rapid	O
,	O
transient	O
activation	O
of	O
extracellular	B-protein
signal-regulated	I-protein
kinase	I-protein
1	I-protein
(	O
ERK1	B-protein
)	O
and	O
ERK2	B-protein
in	O
microglia	B-cell_type
and	O
ERK2	B-protein
in	O
THP1	B-cell_line
monocytes	I-cell_line
.	O

A	O
second	O
superfamily	B-protein
member	I-protein
,	O
p38	B-protein
MAPK	I-protein
,	O
was	O
also	O
activated	O
with	O
similar	O
kinetics	O
.	O

Scavenger	B-protein
receptor	I-protein
and	O
receptor	B-protein
for	I-protein
advanced	I-protein
glycated	I-protein
end	I-protein
products	I-protein
(	O
RAGE	B-protein
)	O
ligands	O
failed	O
to	O
activate	O
ERK	B-protein
and	O
p38	B-protein
MAPK	I-protein
in	O
the	O
absence	O
of	O
significant	O
increases	O
in	O
protein	O
tyrosine	O
phosphorylation	O
,	O
demonstrating	O
that	O
scavenger	B-protein
receptors	I-protein
and	O
RAGE	B-protein
are	O
not	O
linked	O
to	O
these	O
pathways	O
.	O

Importantly	O
,	O
the	O
stress-activated	B-protein
protein	I-protein
kinases	I-protein
(	O
SAPKs	B-protein
)	O
were	O
not	O
significantly	O
activated	O
in	O
response	O
to	O
Abeta	B-protein
.	O

Downstream	O
effectors	O
of	O
the	O
MAPK	O
signal	O
transduction	O
cascades	O
include	O
MAPKAP	B-protein
kinases	I-protein
,	O
such	O
as	O
RSK1	B-protein
and	O
RSK2	B-protein
,	O
as	O
well	O
as	O
transcription	B-protein
factors	I-protein
.	O

Exposure	O
of	O
microglia	B-cell_type
and	O
THP1	B-cell_line
monocytes	I-cell_line
to	O
Abeta	B-protein
resulted	O
in	O
the	O
activation	O
of	O
RSK1	B-protein
and	O
RSK2	B-protein
and	O
phosphorylation	O
of	O
cAMP	B-protein
response	I-protein
element-binding	I-protein
protein	I-protein
at	O
Ser133	O
,	O
providing	O
a	O
mechanism	O
for	O
Abeta	B-protein
-induced	O
changes	O
in	O
gene	O
expression	O

The	NULL
Journal	NULL
of	NULL
Neuroscience	NULL
,	NULL
June	NULL
15	NULL
,	NULL
1998	NULL
,	NULL
18	NULL
(	NULL
12	NULL
)	NULL
:4451-4460	NULL
B-Amyloid	NULL
Fibrils	NULL
Activate	NULL
Parallel	NULL
Mitogen-Activated	NULL
Protein	NULL
Kinase	NULL
Pathways	NULL
in	NULL
Microglia	NULL
and	NULL
THP1	NULL
Monocytes	NULL
Douglas	NULL
R.	NULL
McDonald	NULL
,	NULL
Maria	NULL
E.	NULL
Bamberger	NULL
,	NULL
Colin	NULL
K.	NULL
Combs	NULL
,	NULL
and	NULL
Gary	NULL
E.	NULL
Landreth	NULL
Alzheimer	NULL
Research	NULL
Laboratory	NULL
,	NULL
Department	NULL
of	NULL
Neurology	NULL
and	NULL
Neurosciences	NULL
,	NULL
Case	NULL
Western	NULL
Reserve	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Cleveland	NULL
,	NULL
Ohio	NULL
44106	NULL
The	NULL
senile	NULL
plaques	NULL
of	NULL
Alzheimer	NULL
's	NULL
disease	NULL
are	NULL
foci	NULL
of	NULL
local	NULL
inflammatory	NULL
responses	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
acute	NULL
phase	NULL
proteins	NULL
and	NULL
oxidative	NULL
damage	NULL
.	NULL

Fibrillar	NULL
forms	NULL
of	NULL
B-amyloid	NULL
(	NULL
AB	NULL
)	NULL
,	NULL
which	NULL
are	NULL
the	NULL
primary	NULL
constituents	NULL
of	NULL
senile	NULL
plaques	NULL
,	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
tyrosine	NULL
kinase-dependent	NULL
signal	NULL
transduction	NULL
cascades	NULL
,	NULL
resulting	NULL
in	NULL
inflammatory	NULL
responses	NULL
in	NULL
microglia	NULL
.	NULL

However	NULL
,	NULL
the	NULL
downstream	NULL
signaling	NULL
pathways	NULL
mediating	NULL
AB-induced	NULL
inflammatory	NULL
events	NULL
are	NULL
not	NULL
well	NULL
characterized	NULL
.	NULL

We	NULL
report	NULL
that	NULL
exposure	NULL
of	NULL
primary	NULL
rat	NULL
microglia	NULL
and	NULL
human	NULL
THP1	NULL
monocytes	NULL
to	NULL
fibrillar	NULL
AB	NULL
results	NULL
in	NULL
the	NULL
tyrosine	NULL
kinase-dependent	NULL
activation	NULL
of	NULL
two	NULL
parallel	NULL
signal	NULL
transduction	NULL
cascades	NULL
involving	NULL
members	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
superfamily	NULL
.	NULL

AB	NULL
stimulated	NULL
the	NULL
rapid	NULL
,	NULL
transient	NULL
activation	NULL
of	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
1	NULL
(	NULL
ERK1	NULL
)	NULL
and	NULL
ERK2	NULL
in	NULL
microglia	NULL
and	NULL
ERK2	NULL
in	NULL
THP1	NULL
monocytes	NULL
.	NULL

A	NULL
second	NULL
superfamily	NULL
member	NULL
,	NULL
p38	NULL
MAPK	NULL
,	NULL
was	NULL
also	NULL
activated	NULL
with	NULL
sim-	NULL
ilar	NULL
kinetics	NULL
.	NULL

Scavenger	NULL
receptor	NULL
and	NULL
receptor	NULL
for	NULL
advanced	NULL
glycated	NULL
end	NULL
products	NULL
(	NULL
RAGE	NULL
)	NULL
ligands	NULL
failed	NULL
to	NULL
activate	NULL
ERK	NULL
and	NULL
p38	NULL
MAPK	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
significant	NULL
increases	NULL
in	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
demonstrating	NULL
that	NULL
scavenger	NULL
receptors	NULL
and	NULL
RAGE	NULL
are	NULL
not	NULL
linked	NULL
to	NULL
these	NULL
pathways	NULL
.	NULL

Importantly	NULL
,	NULL
the	NULL
stress-activated	NULL
protein	NULL
kinases	NULL
(	NULL
SAPKs	NULL
)	NULL
were	NULL
not	NULL
significantly	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
AB	NULL
.	NULL

Downstream	NULL
effectors	NULL
of	NULL
the	NULL
MAPK	NULL
signal	NULL
transduction	NULL
cascades	NULL
include	NULL
MAPKAP	NULL
kinases	NULL
,	NULL
such	NULL
as	NULL
RSK1	NULL
and	NULL
RSK2	NULL
,	NULL
as	NULL
well	NULL
as	NULL
transcription	NULL
factors	NULL
.	NULL

Exposure	NULL
of	NULL
microglia	NULL
and	NULL
THP1	NULL
monocytes	NULL
to	NULL
AB	NULL
resulted	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
RSK1	NULL
and	NULL
RSK2	NULL
and	NULL
phosphorylation	NULL
of	NULL
cAMP	NULL
response	NULL
element-binding	NULL
protein	NULL
at	NULL
Ser	NULL
'	NULL
>	NULL
,	NULL
providing	NULL
a	NULL
mechanism	NULL
for	NULL
AB-induced	NULL
changes	NULL
in	NULL
gene	NULL
expression	NULL
.	NULL

Key	NULL
words	NULL
:	NULL
Alzheimer	NULL
's	NULL
disease	NULL
;	NULL
B-amyloid	NULL
;	NULL
microglia	NULL
;	NULL
THP1	NULL
monocytes	NULL
;	NULL
signal	NULL
transduction	NULL
;	NULL
tyrosine	NULL
kinase	NULL
;	NULL
MAPK	NULL
super-family	NULL
;	NULL
piceatannol	NULL
;	NULL
inflammatory	NULL
;	NULL
RAGE	NULL
;	NULL
scavenger	NULL
receptor	NULL
The	NULL
senile	NULL
plaques	NULL
of	NULL
Alzheimer	NULL
's	NULL
disease	NULL
(	NULL
AD	NULL
)	NULL
are	NULL
sites	NULL
of	NULL
inflammatory	NULL
processes	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
degenerating	NULL
neurons	NULL
and	NULL
numerous	NULL
reactive	NULL
microglia	NULL
and	NULL
astrocytes	NULL
associated	NULL
with	NULL
the	NULL
plaques	NULL
(	NULL
Itagaki	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
plaques	NULL
contain	NULL
acute	NULL
phase	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
cytokines	NULL
,	NULL
complement	NULL
proteins	NULL
,	NULL
proteases	NULL
,	NULL
and	NULL
protease	NULL
inhibitors	NULL
that	NULL
are	NULL
secreted	NULL
by	NULL
microglia	NULL
(	NULL
Abraham	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Griffin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Itagaki	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
McGeer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Cataldo	NULL
and	NULL
Nixon	NULL
,	NULL
1990	NULL
;	NULL
Bauer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Walker	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
main	NULL
protein	NULL
component	NULL
of	NULL
senile	NULL
plaques	NULL
is	NULL
the	NULL
B-amyloid	NULL
protein	NULL
(	NULL
AB	NULL
)	NULL
,	NULL
a	NULL
39-43	NULL
amino	NULL
acid	NULL
product	NULL
of	NULL
the	NULL
larger	NULL
B-amyloid	NULL
precursor	NULL
(	NULL
Glenner	NULL
and	NULL
Wong	NULL
,	NULL
1984	NULL
;	NULL
Masters	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
)	NULL
.	NULL

Although	NULL
considerable	NULL
genetic	NULL
evidence	NULL
implicates	NULL
Af	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
AD	NULL
(	NULL
Selkoe	NULL
,	NULL
1996	NULL
)	NULL
,	NULL
a	NULL
direct	NULL
causal	NULL
link	NULL
remains	NULL
to	NULL
be	NULL
established	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
demonstrated	NULL
that	NULL
exposure	NULL
of	NULL
primary	NULL
cultures	NULL
of	NULL
rat	NULL
microglia	NULL
and	NULL
human	NULL
THP1	NULL
monocytes	NULL
to	NULL
fibrillar	NULL
forms	NULL
of	NULL
Af	NULL
resulted	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
that	NULL
initiate	NULL
the	NULL
activation	NULL
of	NULL
complex	NULL
signaling	NULL
pathways	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Exposure	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
AB	NULL
led	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
Lyn	NULL
,	NULL
Syk	NULL
,	NULL
and	NULL
the	NULL
focal	NULL
adhesion	NULL
kinase	NULL
(	NULL
FAK	NULL
)	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
toxic	NULL
superoxide	NULL
radicals	NULL
(	NULL
McDonald	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Exposure	NULL
of	NULL
microglia	NULL
and	NULL
monocytes	NULL
to	NULL
AB	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
stimulate	NULL
increased	NULL
expression	NULL
of	NULL
interleukin	NULL
18	NULL
(	NULL
IL-1	NULL
$	NULL
B	NULL
)	NULL
Received	NULL
Sept.	NULL
23	NULL
,	NULL
1997	NULL
;	NULL
revised	NULL
March	NULL
27	NULL
,	NULL
1998	NULL
;	NULL
accepted	NULL
March	NULL
30	NULL
,	NULL
1998	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institute	NULL
on	NULL
Aging	NULL
Grant	NULL
AGO8012	NULL
.	NULL

Correspondence	NULL
should	NULL
be	NULL
addressed	NULL
to	NULL
Dr.	NULL
Gary	NULL
Landreth	NULL
,	NULL
Alzheimer	NULL
Research	NULL
Laboratory	NULL
,	NULL
Case	NULL
Western	NULL
Reserve	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
10900	NULL
Euclid	NULL
Avenue	NULL
,	NULL
Cleveland	NULL
,	NULL
OH	NULL
44106-4928	NULL
.	NULL

Copyright	NULL
©	NULL
1998	NULL
Society	NULL
for	NULL
Neuroscience	NULL
-	NULL
0270-6474/98/184451-10§05.00/0	NULL
(	NULL
Walker	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Lorton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
AB	NULL
is	NULL
capable	NULL
of	NULL
directly	NULL
activating	NULL
inflammatory	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
in	NULL
microglia	NULL
and	NULL
monocytic	NULL
cells	NULL
.	NULL

The	NULL
downstream	NULL
components	NULL
of	NULL
this	NULL
AfB-stimulated	NULL
inflammatory	NULL
signal	NULL
transduction	NULL
pathway	NULL
have	NULL
not	NULL
been	NULL
characterized	NULL
.	NULL

Recently	NULL
,	NULL
three	NULL
receptors	NULL
have	NULL
been	NULL
identified	NULL
that	NULL
can	NULL
interact	NULL
with	NULL
Af	NULL
:	NULL
the	NULL
scavenger	NULL
receptor	NULL
(	NULL
El	NULL
Khoury	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Paresce	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
the	NULL
receptor	NULL
for	NULL
glycated	NULL
end	NULL
products	NULL
(	NULL
RAGE	NULL
)	NULL
(	NULL
Yan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
and	NULL
the	NULL
serpin-enzyme	NULL
complex	NULL
receptor	NULL
(	NULL
Boland	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

However	NULL
,	NULL
these	NULL
receptors	NULL
are	NULL
not	NULL
linked	NULL
to	NULL
the	NULL
rapid	NULL
activation	NULL
of	NULL
tyrosine	NULL
kinases	NULL
,	NULL
and	NULL
we	NULL
have	NULL
been	NULL
unable	NULL
to	NULL
detect	NULL
the	NULL
subsequent	NULL
production	NULL
of	NULL
superoxide	NULL
radicals	NULL
after	NULL
ligand	NULL
binding	NULL
(	NULL
McDonald	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
,	NULL
thus	NULL
it	NULL
is	NULL
unclear	NULL
how	NULL
each	NULL
of	NULL
these	NULL
receptors	NULL
is	NULL
coupled	NULL
to	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

The	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
cascade	NULL
represents	NULL
a	NULL
prototypic	NULL
signal	NULL
transduction	NULL
system	NULL
through	NULL
which	NULL
extracellular	NULL
stimuli	NULL
are	NULL
transduced	NULL
.	NULL

The	NULL
MAPK	NULL
superfamily	NULL
comprises	NULL
three	NULL
distinct	NULL
,	NULL
but	NULL
similarly	NULL
organized	NULL
,	NULL
signaling	NULL
pathways	NULL
.	NULL

The	NULL
central	NULL
elements	NULL
of	NULL
these	NULL
cascades	NULL
are	NULL
extracellular	NULL
signal-regulated	NULL
kinases	NULL
(	NULL
ERKs	NULL
)	NULL
,	NULL
stress-activated	NULL
protein	NULL
kinases	NULL
(	NULL
SAPKs	NULL
)	NULL
,	NULL
also	NULL
termed	NULL
Jun	NULL
N-terminal	NULL
kinases	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
ERKs	NULL
occurs	NULL
in	NULL
response	NULL
to	NULL
growth	NULL
factor	NULL
stimulation	NULL
and	NULL
also	NULL
after	NULL
activation	NULL
of	NULL
high-affinity	NULL
IgG	NULL
receptors	NULL
(	NULL
FeyRI	NULL
)	NULL
(	NULL
Durden	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
SAPKs	NULL
and	NULL
p38	NULL
MAPK	NULL
occurs	NULL
after	NULL
exposure	NULL
to	NULL
environmental	NULL
stresses	NULL
,	NULL
such	NULL
as	NULL
UV	NULL
irradiation	NULL
,	NULL
hyperosmolarity	NULL
,	NULL
and	NULL
endotoxin	NULL
(	NULL
Freshney	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Han	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Lee	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Cano	NULL
and	NULL
Mahadevan	NULL
,	NULL
1995	NULL
;	NULL
Raingeaud	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
colony-stimulating	NULL
factor	NULL
1	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
and	NULL
IL-3	NULL
4452	NULL
J	NULL
.	NULL

Neurosci	NULL
.	NULL

,	NULL
June	NULL
15	NULL
,	NULL
1998	NULL
,	NULL
18	NULL
(	NULL
12	NULL
)	NULL
:4451-4460	NULL
were	NULL
found	NULL
to	NULL
activate	NULL
the	NULL
ERKs	NULL
and	NULL
p38	NULL
MAPK	NULL
in	NULL
mast	NULL
cells	NULL
and	NULL
macrophages	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
ERK	NULL
s	NULL
and	NULL
p38	NULL
MAPK	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
development	NULL
and	NULL
function	NULL
of	NULL
immune	NULL
cells	NULL
(	NULL
Foltz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
substrates	NULL
of	NULL
MAPK	NULL
family	NULL
members	NULL
include	NULL
MAPKAP	NULL
kinases	NULL
,	NULL
such	NULL
as	NULL
RSK1	NULL
,	NULL
RSK2	NULL
,	NULL
MAPKAP	NULL
kinase-2	NULL
,	NULL
MAPKAP	NULL
kinase-3	NULL
,	NULL
and	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
Elk1	NULL
,	NULL
Jun	NULL
,	NULL
CHOP	NULL
,	NULL
activating	NULL
transcription	NULL
factor	NULL
2	NULL
,	NULL
and	NULL
MEFC2	NULL
(	NULL
Pulverer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Stokoe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992a	NULL
,	NULL
b	NULL
;	NULL
Gille	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Blenis	NULL
,	NULL
1993	NULL
;	NULL
Grove	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Raingeaud	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
McLaughlin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Wang	NULL
and	NULL
Ron	NULL
,	NULL
1996	NULL
;	NULL
Han	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
MAPK	NULL
signaling	NULL
cascades	NULL
are	NULL
one	NULL
of	NULL
the	NULL
major	NULL
pathways	NULL
linking	NULL
extracellular	NULL
stimuli	NULL
to	NULL
transcriptional	NULL
activation	NULL
and	NULL
gene	NULL
expression	NULL
.	NULL

Exposure	NULL
of	NULL
microglia	NULL
to	NULL
AB	NULL
results	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
superoxide	NULL
radicals	NULL
and	NULL
elevated	NULL
IL-18	NULL
expression	NULL
(	NULL
Walker	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
El	NULL
Khoury	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Lorton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
McDonald	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
led	NULL
us	NULL
to	NULL
test	NULL
whether	NULL
MAPK	NULL
family	NULL
members	NULL
are	NULL
components	NULL
of	NULL
an	NULL
AB-stimulated	NULL
signal	NULL
transduction	NULL
cascade	NULL
mediating	NULL
these	NULL
effects	NULL
.	NULL

We	NULL
report	NULL
that	NULL
exposure	NULL
of	NULL
microglia	NULL
and	NULL
THP1	NULL
monocytes	NULL
to	NULL
fibrillar	NULL
AB	NULL
peptides	NULL
resulted	NULL
in	NULL
the	NULL
tyrosine	NULL
kinase-dependent	NULL
activation	NULL
of	NULL
the	NULL
MAPK	NULL
family	NULL
members	NULL
ERK1	NULL
,	NULL
ERK2	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
.	NULL

SAPKs	NULL
were	NULL
not	NULL
significantly	NULL
activated	NULL
by	NULL
exposure	NULL
to	NULL
Af	NULL
.	NULL

Furthermore	NULL
,	NULL
stimulation	NULL
of	NULL
these	NULL
cells	NULL
with	NULL
AB	NULL
resulted	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
RSK1	NULL
and	NULL
RSK2	NULL
and	NULL
phosphorylation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
cAMP	NULL
response	NULL
element-binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
at	NULL
serine	NULL
133	NULL
,	NULL
a	NULL
critical	NULL
regulatory	NULL
site	NULL
for	NULL
transcriptional	NULL
activation	NULL
(	NULL
Gonzalez	NULL
and	NULL
Montminy	NULL
,	NULL
1989	NULL
;	NULL
Ginty	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
providing	NULL
a	NULL
mechanistic	NULL
link	NULL
between	NULL
Af	NULL
and	NULL
the	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

Importantly	NULL
,	NULL
exposure	NULL
of	NULL
THP1	NULL
monocytes	NULL
to	NULL
scavenger	NULL
receptor	NULL
and	NULL
RAGE	NULL
ligands	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
significant	NULL
activation	NULL
of	NULL
the	NULL
MAP	NULL
kinases	NULL
.	NULL

These	NULL
observations	NULL
demonstrate	NULL
that	NULL
scavenger	NULL
receptors	NULL
and	NULL
RAGE	NULL
are	NULL
linked	NULL
to	NULL
signal	NULL
transduction	NULL
cascades	NULL
distinct	NULL
from	NULL
those	NULL
activated	NULL
by	NULL
fibrillar	NULL
AB	NULL
and	NULL
provide	NULL
support	NULL
for	NULL
the	NULL
existence	NULL
of	NULL
other	NULL
AfB-interactive	NULL
receptors	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Materials	NULL
.	NULL

Anti-phospho-ERK	NULL
,	NULL
anti-phospho-p38	NULL
MAPK	NULL
,	NULL
anti-phospho-CREB	NULL
,	NULL
anti-p38	NULL
,	NULL
and	NULL
anti-CREB	NULL
antibodies	NULL
were	NULL
obtained	NULL
from	NULL
New	NULL
England	NULL
Biolabs	NULL
(	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Anti-ERK	NULL
was	NULL
obtained	NULL
from	NULL
Zymed	NULL
(	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Anti-JNK1	NULL
,	NULL
anti-ERK2	NULL
,	NULL
anti-RSK1	NULL
,	NULL
anti-RSK2	NULL
,	NULL
and	NULL
protein	NULL
G-agarose	NULL
were	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Anti-FoeyRII	NULL
[	NULL
monoclonal	NULL
antibody	NULL
(	NULL
mAb	NULL
)	NULL
IV.3	NULL
)	NULL
]	NULL
was	NULL
obtained	NULL
from	NULL
Medarex	NULL
(	NULL
West	NULL
Lebanon	NULL
,	NULL
NH	NULL
)	NULL
.	NULL

Goat	NULL
anti-mouse	NULL
F	NULL
(	NULL
ab	NULL
)	NULL
,	NULL
was	NULL
obtained	NULL
from	NULL
Cappel-Worthington	NULL
(	NULL
Durham	NULL
,	NULL
NC	NULL
)	NULL
.	NULL

Affinity-purified	NULL
horseradish	NULL
peroxidase-conjugated	NULL
goat	NULL
anti-mouse	NULL
,	NULL
goat	NULL
anti-rabbit	NULL
,	NULL
and	NULL
porcine	NULL
anti-goat	NULL
secondary	NULL
antibodies	NULL
,	NULL
piceatannol	NULL
,	NULL
and	NULL
protein	NULL
A-agarose	NULL
were	NULL
obtained	NULL
from	NULL
Boehringer	NULL
Mannheim	NULL
(	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
.	NULL

Piceatannol	NULL
was	NULL
prepared	NULL
as	NULL
a	NULL
12.3	NULL
mm	NULL
solution	NULL
in	NULL
30	NULL
%	NULL
DMSO	NULL
.	NULL

Anti-phosphotyrosine	NULL
mAb	NULL
PY20	NULL
was	NULL
obtained	NULL
from	NULL
Transduction	NULL
Laboratories	NULL
(	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
.	NULL

Anti-phosphotyrosine	NULL
mAb	NULL
4G10	NULL
and	NULL
S6	NULL
peptide	NULL
were	NULL
obtained	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

The	NULL
MEK	NULL
inhibitor	NULL
PD98059	NULL
was	NULL
obtained	NULL
from	NULL
Calbiochem	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Glutathione-Sepharose	NULL
was	NULL
obtained	NULL
from	NULL
Pharmacia	NULL
(	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

A	NULL
peptide	NULL
comprising	NULL
amino	NULL
acids	NULL
25-35	NULL
of	NULL
B-amyloid	NULL
(	NULL
AB25-35	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
American	NULL
Peptide	NULL
Co.	NULL
(	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
a	NULL
peptide	NULL
comprising	NULL
amino	NULL
acids	NULL
25-35	NULL
of	NULL
B-amyloid	NULL
in	NULL
a	NULL
scrambled	NULL
sequence	NULL
(	NULL
SC25-35	NULL
;	NULL
NAMGKILSGIG	NULL
)	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Dr.	NULL
Kurt	NULL
Brunden	NULL
(	NULL
Gliatech	NULL
,	NULL
Inc.	NULL
,	NULL
Cleveland	NULL
,	NULL
OH	NULL
)	NULL
.	NULL

AB25-35	NULL
and	NULL
SC25-35	NULL
were	NULL
resuspended	NULL
in	NULL
sterile	NULL
,	NULL
distilled	NULL
H	NULL
;	NULL
0	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2	NULL
mm	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
37°C	NULL
to	NULL
allow	NULL
fibril	NULL
formation	NULL
(	NULL
Terzi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

AfB1-40	NULL
was	NULL
a	NULL
product	NULL
of	NULL
Bachem	NULL
(	NULL
King	NULL
of	NULL
Prussia	NULL
,	NULL
PA	NULL
)	NULL
and	NULL
was	NULL
resuspended	NULL
in	NULL
sterile	NULL
,	NULL
distilled	NULL
H	NULL
;	NULL
0	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2	NULL
mm	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
week	NULL
at	NULL
37°C	NULL
to	NULL
allow	NULL
fibril	NULL
formation	NULL
.	NULL

Nonfibrillar	NULL
AB1I-40	NULL
was	NULL
prepared	NULL
by	NULL
dissolving	NULL
the	NULL
peptide	NULL
in	NULL
hexafluoroisopropa-nol	NULL
,	NULL
lyophilizing	NULL
,	NULL
and	NULL
resuspending	NULL
in	NULL
sterile	NULL
,	NULL
distilled	NULL
H0	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2	NULL
mm	NULL
(	NULL
Jao	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Acetylated	NULL
low-density	NULL
lipoprotein	NULL
McDonald	NULL
et	NULL
al	NULL
.	NULL

e	NULL
AB-Stimulated	NULL
Activation	NULL
of	NULL
MAP	NULL
Kinases	NULL
in	NULL
Microglia	NULL
(	NULL
AcLDL	NULL
)	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
Frederick	NULL
DeBeer	NULL
(	NULL
University	NULL
of	NULL
Ken-tucky	NULL
)	NULL
.	NULL

Maleylated	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
mBSA	NULL
)	NULL
was	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Haberland	NULL
and	NULL
Fogelman	NULL
,	NULL
1985	NULL
)	NULL
.	NULL

Glycated	NULL
BSA	NULL
(	NULL
AGE	NULL
)	NULL
and	NULL
iron-saturated	NULL
lactoferrin	NULL
(	NULL
L	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Tissue	NULL
culture	NULL
.	NULL

Human	NULL
THP	NULL
]	NULL
monocytic	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI-1640	NULL
(	NULL
Whitaker	NULL
Bioproducts	NULL
,	NULL
Walkersville	NULL
,	NULL
MD	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
5	NULL
X	NULL
m	NULL
B-mercaptoethanol	NULL
,	NULL
5	NULL
mM	NULL
HEPES	NULL
,	NULL
and	NULL
1.5	NULL
pg/ml	NULL
gentamicin	NULL
in	NULL
an	NULL
atmosphere	NULL
of	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

Microglia	NULL
were	NULL
derived	NULL
from	NULL
the	NULL
brains	NULL
of	NULL
neonatal	NULL
rats	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Giulian	NULL
and	NULL
Baker	NULL
,	NULL
1986	NULL
;	NULL
McDonald	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Cell	NULL
stimulation	NULL
.	NULL

THP1	NULL
monocytes	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
or	NULL
microglia	NULL
(	NULL
2	NULL
x	NULL
10®	NULL
cells	NULL
)	NULL
were	NULL
suspended	NULL
in	NULL
250	NULL
ul	NULL
of	NULL
RPMI-1640	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
by	NULL
addition	NULL
of	NULL
peptide	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

In	NULL
some	NULL
instances	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
50	NULL
ug/ml	NULL
piceatannol	NULL
in	NULL
RPMI-1640	NULL
for	NULL
1	NULL
hr	NULL
before	NULL
stimulation	NULL
or	NULL
25	NULL
um	NULL
PD98059	NULL
for	NULL
20	NULL
min	NULL
before	NULL
stimulation	NULL
.	NULL

Low-affinity	NULL
(	NULL
FoyRII	NULL
)	NULL
Ig	NULL
receptors	NULL
were	NULL
cross-linked	NULL
by	NULL
incubation	NULL
of	NULL
1	NULL
X	NULL
10	NULL
``	NULL
THP1	NULL
monocytes	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
anti-FeyRII	NULL
in	NULL
ice-cold	NULL
RPMI	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Cells	NULL
were	NULL
pelleted	NULL
and	NULL
resuspended	NULL
in	NULL
RPMI	NULL
(	NULL
37°C	NULL
)	NULL
and	NULL
20	NULL
ug	NULL
of	NULL
goat	NULL
anti-mouse	NULL
F	NULL
(	NULL
ab	NULL
)	NULL
,	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
and	NULL
were	NULL
lysed	NULL
in	NULL
300	NULL
ul	NULL
of	NULL
ice-cold	NULL
radioimmunoprecipitation	NULL
assay	NULL
(	NULL
RIPA	NULL
)	NULL
buffer	NULL
(	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
20	NULL
mm	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
100	NULL
mm	NULL
NaCl	NULL
,	NULL
1	NULL
mm	NULL
Na	NULL
,	NULL
;	NULL
VO	NULL
,	NULL
,	NULL
40	NULL
mm	NULL
NaF	NULL
,	NULL
5	NULL
mm	NULL
EGTA	NULL
,	NULL
0.2	NULL
%	NULL
SDS	NULL
,	NULL
0.5	NULL
%	NULL
deoxycholate	NULL
,	NULL
and	NULL
0.2	NULL
mm	NULL
PMSF	NULL
)	NULL
for	NULL
Western	NULL
blotting	NULL
or	NULL
Triton	NULL
X-100	NULL
buffer	NULL
(	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
20	NULL
mm	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
100	NULL
mm	NULL
NaCl	NULL
,	NULL
1	NULL
mm	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
,	NULL
40	NULL
mm	NULL
NaF	NULL
,	NULL
5	NULL
mm	NULL
EGTA	NULL
,	NULL
and	NULL
0.2	NULL
mm	NULL
PMSF	NULL
)	NULL
for	NULL
in	NULL
vitro	NULL
kinase	NULL
assays	NULL
.	NULL

Western	NULL
blotting	NULL
.	NULL

Protein	NULL
concentrations	NULL
of	NULL
RIPA	NULL
lysates	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Bradford	NULL
(	NULL
1976	NULL
)	NULL
using	NULL
BSA	NULL
as	NULL
a	NULL
standard	NULL
.	NULL

Sample	NULL
buffer	NULL
was	NULL
added	NULL
to	NULL
aliquots	NULL
(	NULL
50	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
of	NULL
lysates	NULL
,	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
,	NULL
and	NULL
then	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
under	NULL
reducing	NULL
conditions	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
effect	NULL
of	NULL
piceatannol	NULL
on	NULL
AB-stimulated	NULL
activation	NULL
of	NULL
p38	NULL
MAPK	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
500	NULL
pl	NULL
of	NULL
RIPA	NULL
buffer	NULL
,	NULL
immunoprecipitated	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
PY20	NULL
,	NULL
followed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
anti-p38	NULL
MAPK	NULL
antibody	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
PolyScreen	NULL
membranes	NULL
(	NULL
DuPont	NULL
NEN	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
and	NULL
then	NULL
blocked	NULL
in	NULL
TBS-T	NULL
(	NULL
10	NULL
mm	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
100	NULL
mm	NULL
NaCl	NULL
,	NULL
and	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
containing	NULL
3	NULL
%	NULL
BSA	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
incubated	NULL
with	NULL
primary	NULL
antibodies	NULL
overnight	NULL
and	NULL
then	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
TBS-T	NULL
,	NULL
followed	NULL
by	NULL
incubation	NULL
for	NULL
1	NULL
hr	NULL
with	NULL
goat	NULL
anti-rabbit	NULL
,	NULL
goat	NULL
anti-mouse	NULL
,	NULL
or	NULL
porcine	NULL
anti-goat	NULL
secondary	NULL
antibodies	NULL
conjugated	NULL
to	NULL
HRP	NULL
in	NULL
TBS-T	NULL
containing	NULL
5	NULL
%	NULL
nonfat	NULL
dried	NULL
milk	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
TBS-T	NULL
followed	NULL
by	NULL
detection	NULL
with	NULL
an	NULL
ECL	NULL
detection	NULL
system	NULL
(	NULL
DuPont	NULL
NEN	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

In	NULL
some	NULL
instances	NULL
blots	NULL
were	NULL
stripped	NULL
by	NULL
incubation	NULL
in	NULL
stripping	NULL
buffer	NULL
(	NULL
62.5	NULL
mm	NULL
Tris	NULL
,	NULL
pH	NULL
6.8	NULL
,	NULL
100	NULL
mm	NULL
B-mercaptoethanol	NULL
,	NULL
and	NULL
2	NULL
%	NULL
SDS	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
50°C	NULL
and	NULL
then	NULL
reprobed	NULL
with	NULL
other	NULL
antibodies	NULL
.	NULL

Jun	NULL
kinase	NULL
assays	NULL
.	NULL

SAPKs	NULL
were	NULL
isolated	NULL
by	NULL
their	NULL
ability	NULL
to	NULL
bind	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
c-Jun	NULL
.	NULL

A	NULL
glutathione	NULL
S-transferase	NULL
fusion	NULL
protein	NULL
including	NULL
amino	NULL
acids	NULL
5-89	NULL
of	NULL
c-Jun	NULL
(	NULL
gst-Jun	NULL
5-89	NULL
,	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
J.	NULL
Woodgett	NULL
,	NULL
University	NULL
of	NULL
Toronto	NULL
)	NULL
was	NULL
bound	NULL
to	NULL
glutathione-Sepharose	NULL
and	NULL
used	NULL
to	NULL
isolate	NULL
SAPK	NULL
's	NULL
from	NULL
Triton	NULL
X-100	NULL
lysates	NULL
of	NULL
THP1	NULL
monocytes	NULL
(	NULL
Pombo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
Af	NULL
as	NULL
described	NULL
above	NULL
and	NULL
also	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
300	NULL
mm	NULL
NaCl	NULL
for	NULL
30	NULL
min	NULL
,	NULL
followed	NULL
by	NULL
lysis	NULL
in	NULL
300	NULL
ul	NULL
ice-cold	NULL
Triton	NULL
X-100	NULL
buffer	NULL
.	NULL

Triton	NULL
X-100-insoluble	NULL
material	NULL
was	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

We	NULL
added	NULL
40	NULL
ug	NULL
of	NULL
lysate	NULL
protein	NULL
to	NULL
200	NULL
l	NULL
of	NULL
wash	NULL
buffer	NULL
(	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
10	NULL
mm	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
150	NULL
mm	NULL
NaCl	NULL
,	NULL
1	NULL
mm	NULL
Na	NULL
,	NULL
;	NULL
VO	NULL
,	NULL
,	NULL
10	NULL
mm	NULL
NaF	NULL
,	NULL
and	NULL
5	NULL
mm	NULL
EGTA	NULL
)	NULL
containing	NULL
40	NULL
ug	NULL
of	NULL
gst-Jun	NULL
beads	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
gst-Jun	NULL
beads	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
wash	NULL
buffer	NULL
and	NULL
once	NULL
in	NULL
kinase	NULL
buffer	NULL
(	NULL
10	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
10	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
100	NULL
un	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
and	NULL
10	NULL
mM	NULL
NaF	NULL
)	NULL
.	NULL

Kinase	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
duplicate	NULL
by	NULL
addition	NULL
of	NULL
40	NULL
pl	NULL
of	NULL
kinase	NULL
buffer	NULL
containing	NULL
10	NULL
um	NULL
[	NULL
y-*°P	NULL
]	NULL
ATP	NULL
(	NULL
55	NULL
dpm/fmol	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Reactions	NULL
were	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
sample	NULL
buffer	NULL
and	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
.	NULL

Samples	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

The	NULL
gst-Jun	NULL
band	NULL
was	NULL
excised	NULL
from	NULL
the	NULL
gel	NULL
and	NULL
incorporated	NULL
radioactivity	NULL
was	NULL
measured	NULL
by	NULL
Cerenkov	NULL
counting	NULL
.	NULL

RSK	NULL
kinase	NULL
assays	NULL
.	NULL

Triton	NULL
X-100	NULL
buffer	NULL
lysates	NULL
(	NULL
500	NULL
ug	NULL
)	NULL
were	NULL
pre-cleared	NULL
with	NULL
10	NULL
ul	NULL
protein	NULL
A-agarose	NULL
for	NULL
30	NULL
min	NULL
.	NULL

RSK1	NULL
was	NULL
immunoprecipitated	NULL
by	NULL
incubation	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
anti-RSK1	NULL
and	NULL
20	NULL
pl	NULL
of	NULL
protein	NULL
A-agarose	NULL
for	NULL
2	NULL
hr	NULL
at	NULL
4°C	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
Triton	NULL
X-100	NULL
buffer	NULL
and	NULL
once	NULL
in	NULL
TEV	NULL
buffer	NULL
(	NULL
20	NULL
mm	NULL
Tris	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
and	NULL
100	NULL
um	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
)	NULL
.	NULL

To	NULL
isolate	NULL
RSK2	NULL
,	NULL
1	NULL
x	NULL
10	NULL
``	NULL
THP1	NULL
cells	NULL
were	NULL
lysed	NULL
by	NULL
sonication	NULL
in	NULL
TEV	NULL
buffer	NULL
plus	NULL
10	NULL
mm	NULL
p-nitrophenylphosphate	NULL
(	NULL
PNP	NULL
)	NULL
.	NULL

Insoluble	NULL
material	NULL
was	NULL
pelleted	NULL
by	NULL
cen-	NULL
McDonald	NULL
et	NULL
al	NULL
.	NULL

e	NULL
AB-Stimulated	NULL
Activation	NULL
of	NULL
MAP	NULL
Kinases	NULL
in	NULL
Microglia	NULL
0	NULL
1	NULL
2	NULL
3	NULL
5	NULL
10	NULL
...	NULL
.	NULL

**	NULL
``	NULL
|-103	NULL
kDa	NULL
wth	NULL
|	NULL
~*	NULL
``	NULL
yf	NULL
I-44	NULL
minutes	NULL
Blot	NULL
:	NULL
Anti-phosphotyrosine	NULL
Figure	NULL
1	NULL
.	NULL

Fibrillar	NULL
AB	NULL
stimulates	NULL
rapid	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
THP1	NULL
monocytes	NULL
.	NULL

THP1	NULL
monocytes	NULL
were	NULL
stimulated	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
with	NULL
50	NULL
um	NULL
A8B25-35	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
tyrosine	NULL
phosphoproteins	NULL
was	NULL
performed	NULL
on	NULL
RIPA	NULL
lysates	NULL
(	NULL
50	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
using	NULL
monoclonal	NULL
anti-phosphotyrosine	NULL
antibodies	NULL
(	NULL
4610	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
molecular	NULL
weight	NULL
standards	NULL
(	NULL
in	NULL
kilodaltons	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

trifugation	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Lysates	NULL
(	NULL
800	NULL
ug	NULL
)	NULL
were	NULL
bound	NULL
to	NULL
150	NULL
ul	NULL
of	NULL
Mono	NULL
Q	NULL
resin	NULL
for	NULL
5	NULL
min	NULL
and	NULL
washed	NULL
for	NULL
5	NULL
min	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
TEV	NULL
buffer	NULL
plus	NULL
50	NULL
mm	NULL
NaCl	NULL
,	NULL
and	NULL
RSK2	NULL
was	NULL
eluted	NULL
with	NULL
two	NULL
washes	NULL
of	NULL
300	NULL
ul	NULL
of	NULL
TEV	NULL
buffer	NULL
plus	NULL
250	NULL
mm	NULL
NaCl	NULL
(	NULL
Xing	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

RSK2	NULL
eluents	NULL
were	NULL
collected	NULL
and	NULL
immunoprecipitated	NULL
by	NULL
incubation	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
anti-RSK2	NULL
and	NULL
20	NULL
ul	NULL
of	NULL
protein	NULL
G-agarose	NULL
for	NULL
2	NULL
hr	NULL
at	NULL
4°C	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
Triton	NULL
X-100	NULL
buffer	NULL
and	NULL
once	NULL
in	NULL
TEV	NULL
buffer	NULL
.	NULL

Washed	NULL
immune	NULL
complexes	NULL
were	NULL
assayed	NULL
by	NULL
phosphorylation	NULL
of	NULL
S6	NULL
peptide	NULL
(	NULL
Pelech	NULL
and	NULL
Krebs	NULL
,	NULL
1987	NULL
)	NULL
in	NULL
50	NULL
pl	NULL
of	NULL
kinase	NULL
buffer	NULL
(	NULL
20	NULL
mm	NULL
Tris	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
10	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
2	NULL
mm	NULL
MnCl	NULL
;	NULL
,	NULL
10	NULL
un	NULL
[	NULL
y-*°P	NULL
]	NULL
ATP	NULL
(	NULL
10	NULL
dpm/fmol	NULL
)	NULL
,	NULL
10	NULL
um	NULL
S6	NULL
peptide	NULL
,	NULL
and	NULL
10	NULL
mm	NULL
PNP	NULL
)	NULL
.	NULL

Reactions	NULL
were	NULL
performed	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
min	NULL
and	NULL
terminated	NULL
by	NULL
removal	NULL
of	NULL
supernatants	NULL
from	NULL
the	NULL
immune	NULL
complexes	NULL
and	NULL
addition	NULL
of	NULL
35	NULL
ul	NULL
of	NULL
10	NULL
%	NULL
trichloroacetic	NULL
acid	NULL
and	NULL
10	NULL
ul	NULL
of	NULL
BSA	NULL
(	NULL
1	NULL
mg/ml	NULL
)	NULL
.	NULL

Supernatants	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
,	NULL
and	NULL
precipitated	NULL
proteins	NULL
were	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
for	NULL
5	NULL
min	NULL
.	NULL

Aliquots	NULL
(	NULL
20	NULL
Ll	NULL
)	NULL
of	NULL
supernatants	NULL
containing	NULL
S6	NULL
peptide	NULL
were	NULL
spotted	NULL
onto	NULL
P81	NULL
phosphocellulose	NULL
paper	NULL
in	NULL
triplicate	NULL
and	NULL
washed	NULL
three	NULL
times	NULL
for	NULL
5	NULL
min	NULL
each	NULL
in	NULL
75	NULL
mm	NULL
phosphoric	NULL
acid	NULL
.	NULL

Incorporation	NULL
of	NULL
[	NULL
°P	NULL
]	NULL
ATP	NULL
into	NULL
the	NULL
S6	NULL
peptide	NULL
was	NULL
quantitated	NULL
by	NULL
Cerenkov	NULL
counting	NULL
.	NULL

Sample	NULL
buffer	NULL
(	NULL
30	NULL
pl	NULL
)	NULL
was	NULL
added	NULL
to	NULL
immune	NULL
complexes	NULL
followed	NULL
by	NULL
boiling	NULL
for	NULL
3	NULL
min	NULL
for	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
RSK1	NULL
levels	NULL
.	NULL

RESULTS	NULL
AB	NULL
peptides	NULL
stimulate	NULL
rapid	NULL
,	NULL
transient	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
THP1	NULL
monocytes	NULL
Signal	NULL
transduction	NULL
through	NULL
tyrosine	NULL
kinases	NULL
characteristically	NULL
leads	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
serine-threonine	NULL
kinases	NULL
that	NULL
constitute	NULL
downstream	NULL
elements	NULL
of	NULL
signal	NULL
transduction	NULL
cascades	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
microglia	NULL
and	NULL
THP1	NULL
monocytes	NULL
with	NULL
fibrillar	NULL
forms	NULL
of	NULL
AB	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
stimulate	NULL
production	NULL
of	NULL
superoxide	NULL
and	NULL
increased	NULL
expression	NULL
of	NULL
IL-18	NULL
(	NULL
Walker	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
El	NULL
Khoury	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Lorton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
McDonald	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
biologically	NULL
active	NULL
domain	NULL
within	NULL
AB	NULL
was	NULL
found	NULL
to	NULL
be	NULL
restricted	NULL
to	NULL
amino	NULL
acids	NULL
25-35	NULL
at	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
Af	NULL
(	NULL
Yankner	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Meda	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Lorton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
McDonald	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

This	NULL
region	NULL
possesses	NULL
a	NULL
B-pleated	NULL
sheet	NULL
structure	NULL
and	NULL
forms	NULL
fibrils	NULL
in	NULL
aqueous	NULL
solution	NULL
(	NULL
Terzi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
THP1	NULL
monocytes	NULL
with	NULL
fibrillar	NULL
AB25-35	NULL
rapidly	NULL
elicited	NULL
an	NULL
increase	NULL
in	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
that	NULL
reached	NULL
maximal	NULL
levels	NULL
within	NULL
1	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

AB	NULL
peptides	NULL
activate	NULL
ERKs	NULL
in	NULL
THP1	NULL
monocytes	NULL
and	NULL
microglia	NULL
We	NULL
tested	NULL
whether	NULL
AB-mediated	NULL
stimulation	NULL
of	NULL
tyrosine	NULL
kinases	NULL
in	NULL
microglia	NULL
and	NULL
THP1	NULL
monocytes	NULL
led	NULL
to	NULL
the	NULL
subsequent	NULL
activation	NULL
of	NULL
members	NULL
of	NULL
the	NULL
MAPK	NULL
superfamily	NULL
.	NULL

Stimulation	NULL
of	NULL
THP1	NULL
monocytes	NULL
with	NULL
fibrillar	NULL
AB1-40	NULL
and	NULL
AB25-35	NULL
led	NULL
to	NULL
J	NULL
.	NULL

Neurosci	NULL
.	NULL

,	NULL
June	NULL
15	NULL
,	NULL
1998	NULL
,	NULL
18	NULL
(	NULL
12	NULL
)	NULL
:4451-4460	NULL
4453	NULL
the	NULL
rapid	NULL
,	NULL
transient	NULL
activation	NULL
of	NULL
ERK2	NULL
,	NULL
which	NULL
reached	NULL
maximal	NULL
levels	NULL
within	NULL
1-2	NULL
min	NULL
and	NULL
returned	NULL
to	NULL
basal	NULL
levels	NULL
in	NULL
5-10	NULL
min	NULL
,	NULL
as	NULL
detected	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
anti-phospho-ERK	NULL
,	NULL
an	NULL
antibody	NULL
that	NULL
specifically	NULL
recognizes	NULL
the	NULL
activated	NULL
,	NULL
tyrosine-phosphorylated	NULL
form	NULL
of	NULL
ERK	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
C	NULL
)	NULL
.	NULL

Nonfibrillar	NULL
AB1-40	NULL
elicited	NULL
modest	NULL
activation	NULL
of	NULL
ERK	NULL
,	NULL
and	NULL
this	NULL
stimulation	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
attributable	NULL
to	NULL
the	NULL
low	NULL
levels	NULL
of	NULL
fibrils	NULL
in	NULL
this	NULL
preparation	NULL
caused	NULL
by	NULL
incomplete	NULL
dissolution	NULL
of	NULL
fibrils	NULL
in	NULL
the	NULL
peptide	NULL
preparation	NULL
and	NULL
their	NULL
subseqent	NULL
formation	NULL
after	NULL
resuspension	NULL
in	NULL
water	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
D	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
previously	NULL
observed	NULL
with	NULL
nonfibrillar	NULL
preparations	NULL
of	NULL
AB25-35	NULL
(	NULL
McDonald	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

THP1	NULL
monocytes	NULL
express	NULL
ERK1	NULL
at	NULL
much	NULL
lower	NULL
levels	NULL
than	NULL
ERK2	NULL
.	NULL

Stimulation	NULL
of	NULL
primary	NULL
cultures	NULL
of	NULL
rat	NULL
microglia	NULL
with	NULL
AB25-35	NULL
led	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
both	NULL
ERK1	NULL
and	NULL
ERK2	NULL
with	NULL
similar	NULL
kinetics	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
the	NULL
AB-induced	NULL
activation	NULL
of	NULL
these	NULL
enzymes	NULL
is	NULL
consistently	NULL
faster	NULL
than	NULL
that	NULL
typically	NULL
observed	NULL
in	NULL
growth	NULL
factor-stimulated	NULL
responses	NULL
.	NULL

A	NULL
scrambled	NULL
peptide	NULL
consisting	NULL
of	NULL
amino	NULL
acids	NULL
25-35	NULL
of	NULL
AB	NULL
(	NULL
SC25-35	NULL
)	NULL
did	NULL
not	NULL
activate	NULL
ERK	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
a	NULL
phospho-ERK	NULL
Western	NULL
blot	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Cross-linking	NULL
of	NULL
low-affinity	NULL
Fey	NULL
receptors	NULL
(	NULL
RII	NULL
)	NULL
for	NULL
5	NULL
min	NULL
led	NULL
to	NULL
dramatic	NULL
increases	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
;	NULL
however	NULL
,	NULL
ERK	NULL
was	NULL
not	NULL
activated	NULL
.	NULL

Scavenger	NULL
receptors	NULL
and	NULL
RAGE	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
capable	NULL
of	NULL
binding	NULL
AB	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
scavenger	NULL
receptor	NULL
ligands	NULL
,	NULL
AcLDL	NULL
and	NULL
mBSA	NULL
,	NULL
and	NULL
RAGE	NULL
ligand	NULL
,	NULL
glycated	NULL
BSA	NULL
plus	NULL
iron-saturated	NULL
lactoferrin	NULL
(	NULL
AGE-L	NULL
)	NULL
,	NULL
to	NULL
activate	NULL
ERK	NULL
.	NULL

Acetylated	NULL
LDL	NULL
,	NULL
maleylated	NULL
BSA	NULL
,	NULL
and	NULL
glycated	NULL
BSA	NULL
plus	NULL
iron-saturated	NULL
lactoferrin	NULL
have	NULL
previously	NULL
been	NULL
shown	NULL
not	NULL
to	NULL
activate	NULL
a	NULL
tyrosine	NULL
kinase-dependent	NULL
pathway	NULL
activated	NULL
by	NULL
AB	NULL
fibrils	NULL
(	NULL
McDonald	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
stimulation	NULL
of	NULL
THP1	NULL
monocytes	NULL
with	NULL
SC25-35	NULL
,	NULL
AcLDL	NULL
,	NULL
mBSA	NULL
,	NULL
AGE-L	NULL
,	NULL
AGE	NULL
alone	NULL
,	NULL
and	NULL
L	NULL
alone	NULL
failed	NULL
to	NULL
affect	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
and	NULL
did	NULL
not	NULL
significantly	NULL
activate	NULL
ERK	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Simultaneous	NULL
exposure	NULL
of	NULL
the	NULL
cells	NULL
to	NULL
AB25-35	NULL
and	NULL
AcLDL	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
Af	NULL
to	NULL
stimulate	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

AB	NULL
peptides	NULL
activate	NULL
p38	NULL
MAPK	NULL
in	NULL
THP1	NULL
monocytes	NULL
and	NULL
microglia	NULL
The	NULL
responses	NULL
of	NULL
microglia	NULL
and	NULL
THP1	NULL
monocytes	NULL
to	NULL
AB	NULL
are	NULL
consistent	NULL
with	NULL
those	NULL
observed	NULL
after	NULL
exposure	NULL
to	NULL
cellular	NULL
stres-sors	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
AB	NULL
activated	NULL
p38	NULL
MAPK	NULL
in	NULL
microglia	NULL
and	NULL
THP1	NULL
monocytes	NULL
.	NULL

Stimulation	NULL
of	NULL
THP1	NULL
monocytes	NULL
with	NULL
AB25-35	NULL
led	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
p38	NULL
MAPK	NULL
with	NULL
a	NULL
time	NULL
course	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
with	NULL
ERK2	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
anti-phospho-p38	NULL
MAPK	NULL
,	NULL
an	NULL
antibody	NULL
that	NULL
specifically	NULL
recognizes	NULL
the	NULL
activated	NULL
,	NULL
tyrosine-phosphorylated	NULL
form	NULL
of	NULL
p38	NULL
MAPK	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
C	NULL
)	NULL
.	NULL

AB25-35	NULL
stimulated	NULL
maximal	NULL
levels	NULL
of	NULL
p38	NULL
MAPK	NULL
activation	NULL
in	NULL
1-2	NULL
min	NULL
that	NULL
returned	NULL
to	NULL
basal	NULL
levels	NULL
within	NULL
10	NULL
min	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
stimulation	NULL
of	NULL
microglia	NULL
with	NULL
AB25-35	NULL
led	NULL
to	NULL
activation	NULL
of	NULL
p38	NULL
MAPK	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
with	NULL
similar	NULL
kinetics	NULL
.	NULL

RAGE	NULL
and	NULL
scavenger	NULL
ligands	NULL
failed	NULL
to	NULL
activate	NULL
p38	NULL
MAPK	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
a	NULL
phospho-p38	NULL
MAPK	NULL
Western	NULL
blot	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

The	NULL
AB-induced	NULL
activation	NULL
of	NULL
p38	NULL
MAPK	NULL
,	NULL
like	NULL
the	NULL
ERK	NULL
s	NULL
,	NULL
was	NULL
very	NULL
rapid	NULL
;	NULL
however	NULL
,	NULL
the	NULL
magnitude	NULL
of	NULL
p38	NULL
phosphorylation	NULL
was	NULL
not	NULL
as	NULL
great	NULL
as	NULL
that	NULL
observed	NULL
in	NULL
the	NULL
ERK	NULL
s.	NULL
AB	NULL
peptides	NULL
do	NULL
not	NULL
significantly	NULL
activate	NULL
SAPKs	NULL
The	NULL
SAPKs	NULL
are	NULL
other	NULL
MAPK	NULL
superfamily	NULL
members	NULL
that	NULL
are	NULL
activated	NULL
by	NULL
stress	NULL
,	NULL
such	NULL
as	NULL
hyperosmolarity	NULL
,	NULL
UV	NULL
irradiation	NULL
,	NULL
and	NULL
4454	NULL
J	NULL
.	NULL

Neurosci	NULL
.	NULL

,	NULL
June	NULL
15	NULL
,	NULL
1998	NULL
,	NULL
18	NULL
(	NULL
12	NULL
)	NULL
:4451-4460	NULL
minutes	NULL
Blot	NULL
:	NULL
pERK	NULL
ERK	NULL
ERKZl	NULL
--	NULL
.	NULL

--	NULL
--	NULL
--	NULL
--	NULL
‘	NULL
ERK	NULL
C.	NULL
2s	NULL
]	NULL
1	NULL
|N	NULL
LAL	NULL
’	NULL
E	NULL
“	NULL
o|	NULL
2	NULL
RD	NULL
a	NULL
|G	NULL
11335404	NULL
}	NULL
<	NULL
Ir	NULL
]	NULL
A	NULL
Blot	NULL
:	NULL
ERK	NULL
win	NULL
CB	NULL
one	NULL
«	NULL
IpERK	NULL
ERKJ	NULL
]	NULL
W	NULL
#	NULL
@	NULL
#	NULL
MERE	NULL
McDonald	NULL
et	NULL
al	NULL
.	NULL

e	NULL
AB-Stimulated	NULL
Activation	NULL
of	NULL
MAP	NULL
Kinases	NULL
in	NULL
Microglia	NULL
B	NULL
.	NULL

0	NULL
2	NULL
minutes	NULL
ERK	NULL
==	NULL
«	NULL
maf	NULL
pERK	NULL
ERK	NULL
]	NULL
!	NULL

=s	NULL
»	NULL
«	NULL
«	NULL
»	NULL
om	NULL
»	NULL
wom	NULL
!	NULL

«	NULL
tite	NULL
-	NULL
sa	NULL
ERK	NULL
]	NULL
*	NULL
--	NULL
«	NULL
#	NULL
»	NULL
ERK	NULL
Blot	NULL
:	NULL
Anti-phosphotyrosine	NULL
Figure	NULL
2	NULL
.	NULL

Fibrillar	NULL
Af	NULL
stimulates	NULL
rapid	NULL
,	NULL
transient	NULL
activation	NULL
of	NULL
ERK1	NULL
and	NULL
ERK2	NULL
in	NULL
THP1	NULL
monocytes	NULL
and	NULL
microglia	NULL
.	NULL

4	NULL
,	NULL
Exposure	NULL
of	NULL
THP1	NULL
monocytes	NULL
to	NULL
50	NULL
um	NULL
AB25-35	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
ERKZ	NULL
.	NULL

Activation	NULL
of	NULL
ERK	NULL
(	NULL
A-C	NULL
)	NULL
was	NULL
determined	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
RIPA	NULL
lysates	NULL
(	NULL
50	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
using	NULL
anti-phospho-ERK	NULL
polyclonal	NULL
antibodies	NULL
(	NULL
top	NULL
panels	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
reprobed	NULL
with	NULL
anti-ERK	NULL
antibody	NULL
(	NULL
bottom	NULL
panels	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Exposure	NULL
of	NULL
primary	NULL
cultures	NULL
of	NULL
rat	NULL
microglia	NULL
to	NULL
50	NULL
um	NULL
AB25-35	NULL
for	NULL
2	NULL
min	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
ERK1	NULL
and	NULL
ERK2	NULL
.	NULL

C	NULL
,	NULL
Ligand	NULL
specificity	NULL
of	NULL
ERK	NULL
activation	NULL
in	NULL
THP1	NULL
monocytes	NULL
.	NULL

THP1	NULL
monocytes	NULL
were	NULL
incubated	NULL
alone	NULL
(	NULL
control	NULL
,	NULL
con	NULL
)	NULL
or	NULL
stimulated	NULL
for	NULL
2	NULL
min	NULL
with	NULL
50	NULL
um	NULL
scrambled	NULL
AB25-35	NULL
(	NULL
§C25-35	NULL
;	NULL
NAMGKILSGIG	NULL
)	NULL
,	NULL
AB25-35	NULL
(	NULL
25-35	NULL
)	NULL
,	NULL
fibrillar	NULL
AB1-40	NULL
(	NULL
7-40	NULL
)	NULL
,	NULL
and	NULL
nonfibrillar	NULL
AB1-40	NULL
(	NULL
NFZ-40	NULL
)	NULL
or	NULL
with	NULL
anti-FeyRII	NULL
cross-linked	NULL
with	NULL
goat	NULL
anti-mouse	NULL
F	NULL
(	NULL
ab	NULL
)	NULL
,	NULL
for	NULL
5	NULL
min	NULL
(	NULL
RII	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
also	NULL
incubated	NULL
with	NULL
the	NULL
RAGE	NULL
ligands	NULL
:	NULL
either	NULL
20	NULL
ug/ml	NULL
L	NULL
,	NULL
AGE	NULL
,	NULL
or	NULL
AGE-L	NULL
.	NULL

The	NULL
scavenger	NULL
receptor	NULL
ligands	NULL
AcLDL	NULL
and	NULL
mBSA	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
cells	NULL
for	NULL
2	NULL
min	NULL
.	NULL

D	NULL
,	NULL
Ligand	NULL
specificity	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
THP1	NULL
monocytes	NULL
.	NULL

THP1	NULL
monocytes	NULL
were	NULL
stimulated	NULL
with	NULL
ligands	NULL
,	NULL
as	NULL
described	NULL
in	NULL
C	NULL
,	NULL
for	NULL
2	NULL
min	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
tyrosine	NULL
phosphoproteins	NULL
was	NULL
performed	NULL
on	NULL
RIPA	NULL
lysates	NULL
(	NULL
50	NULL
ug	NULL
of	NULL
protein	NULL
}	NULL
using	NULL
monoclonal	NULL
anti-phosphotyrosine	NULL
antibodies	NULL
(	NULL
4G10	NULL
)	NULL
.	NULL

protein	NULL
synthesis	NULL
inhibitors	NULL
(	NULL
Freshney	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Han	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Lee	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Cano	NULL
and	NULL
Mahadevan	NULL
,	NULL
1995	NULL
;	NULL
Raingeaud	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

SAPK	NULL
activity	NULL
was	NULL
assayed	NULL
by	NULL
use	NULL
of	NULL
a	NULL
jun	NULL
capture	NULL
assay	NULL
and	NULL
phosphorylation	NULL
of	NULL
the	NULL
SAPK	NULL
substrate	NULL
,	NULL
gst-Jun	NULL
5-89	NULL
(	NULL
Pombo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

THP1	NULL
monocytes	NULL
were	NULL
exposed	NULL
to	NULL
AB25-35	NULL
or	NULL
hyperosmolar	NULL
conditions	NULL
(	NULL
300	NULL
mm	NULL
NaC1	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
THP1	NULL
monocytes	NULL
with	NULL
AB25-35	NULL
did	NULL
not	NULL
significantly	NULL
alter	NULL
the	NULL
activity	NULL
of	NULL
SAPKs	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
enzymes	NULL
are	NULL
not	NULL
linked	NULL
to	NULL
the	NULL
AfB-stimulated	NULL
signal	NULL
transduction	NULL
pathway	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Exposure	NULL
of	NULL
THP1	NULL
monocytes	NULL
to	NULL
hyperosmolar	NULL
conditions	NULL
for	NULL
30	NULL
min	NULL
led	NULL
to	NULL
a	NULL
greater	NULL
than	NULL
fourfold	NULL
increase	NULL
in	NULL
SAPK	NULL
activity	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
ERK	NULL
and	NULL
p38	NULL
MAPK	NULL
pathways	NULL
by	NULL
AB	NULL
peptides	NULL
is	NULL
blocked	NULL
by	NULL
the	NULL
Syk-selective	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
piceatannol	NULL
Stimulation	NULL
of	NULL
microglia	NULL
and	NULL
THP1	NULL
monocytes	NULL
with	NULL
AB	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
parallel	NULL
MAP	NULL
kinase	NULL
pathways	NULL
including	NULL
ERKs	NULL
and	NULL
p38	NULL
MAPK	NULL
.	NULL

Because	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
ERK	NULL
s	NULL
and	NULL
p38	NULL
MAPK	NULL
occur	NULL
over	NULL
similar	NULL
intervals	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
the	NULL
MAPK	NULL
pathways	NULL
were	NULL
downstream	NULL
effectors	NULL
of	NULL
the	NULL
AB-activated	NULL
tyrosine	NULL
kinases	NULL
.	NULL

Exposure	NULL
of	NULL
THP1I	NULL
monocytes	NULL
pretreated	NULL
with	NULL
DMSO	NULL
vehicle	NULL
followed	NULL
by	NULL
stimulation	NULL
with	NULL
AB25-35	NULL
led	NULL
to	NULL
dramatic	NULL
activation	NULL
of	NULL
both	NULL
ERK2	NULL
and	NULL
p38	NULL
MAPK	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
,	NULL
B	NULL
)	NULL
.	NULL

We	NULL
noted	NULL
that	NULL
pretreatment	NULL
of	NULL
cells	NULL
with	NULL
DMSO	NULL
led	NULL
to	NULL
small	NULL
,	NULL
nonspecific	NULL
elevations	NULL
in	NULL
the	NULL
basal	NULL
levels	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
compare	NULL
Figs	NULL
.	NULL

1	NULL
,	NULL
7£	NULL
)	NULL
.	NULL

However	NULL
,	NULL
pretreatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
piceatannol	NULL
,	NULL
a	NULL
Syk-selective	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
(	NULL
Oliver	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
significantly	NULL
reduced	NULL
AfB-induced	NULL
activation	NULL
of	NULL
both	NULL
ERK2	NULL
and	NULL
p38	NULL
MAPK	NULL
(	NULL
Fig	NULL
.	NULL

54,8	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
both	NULL
MAPK	NULL
pathways	NULL
in	NULL
THP1	NULL
monocytes	NULL
by	NULL
AB	NULL
is	NULL
mechanistically	NULL
linked	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
tyrosine	NULL
kinase	NULL
Syk	NULL
.	NULL

RSK1	NULL
and	NULL
RSK2	NULL
are	NULL
activated	NULL
by	NULL
AB	NULL
peptides	NULL
RSK1	NULL
and	NULL
RSK2	NULL
are	NULL
effectors	NULL
of	NULL
the	NULL
ERK	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

THP1	NULL
monocytes	NULL
were	NULL
stimulated	NULL
with	NULL
AB25-35	NULL
,	NULL
and	NULL
subsequent	NULL
RSK	NULL
activation	NULL
was	NULL
assayed	NULL
by	NULL
phosphorylation	NULL
of	NULL
$	NULL
6	NULL
peptide	NULL
,	NULL
an	NULL
RSK	NULL
substrate	NULL
(	NULL
Pelech	NULL
and	NULL
Krebs	NULL
,	NULL
1987	NULL
)	NULL
.	NULL

Maximal	NULL
activation	NULL
of	NULL
RSK1	NULL
occurred	NULL
within	NULL
3	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

64	NULL
)	NULL
.	NULL

RSK2	NULL
was	NULL
also	NULL
activated	NULL
after	NULL
AB	NULL
treatment	NULL
,	NULL
and	NULL
its	NULL
stimulation	NULL
was	NULL
dependent	NULL
on	NULL
previous	NULL
ERK	NULL
activation	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
the	NULL
inhibition	NULL
of	NULL
RSK2	NULL
activation	NULL
after	NULL
pretreatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
PD98059	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
C	NULL
)	NULL
.	NULL

PD98059	NULL
is	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
ERK	NULL
kinase	NULL
MEK	NULL
(	NULL
Dudley	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

AB	NULL
peptides	NULL
stimulate	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
on	NULL
serine	NULL
133	NULL
in	NULL
THP1	NULL
monocytes	NULL
The	NULL
activation	NULL
of	NULL
MAP	NULL
kinase	NULL
family	NULL
members	NULL
,	NULL
either	NULL
directly	NULL
or	NULL
indirectly	NULL
,	NULL
leads	NULL
to	NULL
the	NULL
phosphorylation	NULL
of	NULL
transcriptional	NULL
factors	NULL
and	NULL
activation	NULL
of	NULL
transcription	NULL
(	NULL
Ginty	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
CREB	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
phosphorylated	NULL
and	NULL
activated	NULL
by	NULL
RSK2	NULL
(	NULL
Sheng	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Xing	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

RSK1	NULL
McDonald	NULL
et	NULL
al	NULL
.	NULL

e	NULL
AB-Stimulated	NULL
Activation	NULL
of	NULL
MAP	NULL
Kinases	NULL
in	NULL
Microglia	NULL
A	NULL
.	NULL

0	NULL
1	NULL
2	NULL
3	NULL
|	NULL
5	NULL
10	NULL
|	NULL
minutes	NULL
*=	NULL
®	NULL
u	NULL
un	NULL
un	NULL
ae	NULL
t	NULL
w	NULL
Ww	NULL
#	NULL
**	NULL
|	NULL
phospho-p38	NULL
p38	NULL
C.	NULL
sc	NULL
|	NULL
25-	NULL
Ac-con	NULL
25.35	NULL
]	NULL
35	NULL
RII	NULL
AGE	NULL
LDL	NULL
Blot	NULL
:	NULL
p38	NULL
%	NULL
«	NULL
aan	NULL
.	NULL

walb	NULL
phospho-p38	NULL
p3s	NULL
(	NULL
Wh	NULL
a	NULL
P	NULL
aw	NULL
«	NULL
Dew	NULL
|	NULL
30000	NULL
25000	NULL
7	NULL
20000	NULL
cpm	NULL
into	NULL
jun	NULL
1.	NULL
om	NULL
£	NULL
E	NULL
&	NULL
Ch	NULL
Ner	NULL
we	NULL
CJ	NULL
o	NULL
N	NULL
Figure	NULL
4	NULL
.	NULL

-	NULL
Stimulation	NULL
of	NULL
THP1	NULL
monocytes	NULL
with	NULL
fibrillar	NULL
Af	NULL
does	NULL
not	NULL
lead	NULL
to	NULL
significant	NULL
activation	NULL
of	NULL
SAPKs	NULL
.	NULL

THP1	NULL
monocytes	NULL
were	NULL
stimulated	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
with	NULL
50	NULL
um	NULL
AB25-35	NULL
or	NULL
300	NULL
mm	NULL
NaCl	NULL
.	NULL

SAPK	NULL
activity	NULL
was	NULL
measured	NULL
using	NULL
c-Jun5-89	NULL
as	NULL
a	NULL
substrate	NULL
.	NULL

Proteins	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
the	NULL
gel	NULL
was	NULL
dried	NULL
,	NULL
and	NULL
c-Jun	NULL
protein	NULL
was	NULL
excised	NULL
and	NULL
subjected	NULL
to	NULL
Cerenkov	NULL
counting	NULL
.	NULL

and	NULL
RSK2	NULL
are	NULL
phosphorylated	NULL
and	NULL
activated	NULL
by	NULL
ERK1	NULL
and	NULL
ERK2	NULL
(	NULL
Blenis	NULL
,	NULL
1993	NULL
;	NULL
Xing	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
and	NULL
,	NULL
thus	NULL
,	NULL
are	NULL
regulated	NULL
through	NULL
activation	NULL
of	NULL
the	NULL
MAPK	NULL
cascade	NULL
.	NULL

We	NULL
examined	NULL
whether	NULL
stimulation	NULL
of	NULL
THP1	NULL
monocytes	NULL
and	NULL
microglia	NULL
with	NULL
AB25-35	NULL
led	NULL
to	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
anti-phospho-CREB	NULL
,	NULL
an	NULL
antibody	NULL
that	NULL
specifically	NULL
recognizes	NULL
CREB	NULL
that	NULL
has	NULL
been	NULL
phosphorylated	NULL
on	NULL
serine	NULL
133	NULL
,	NULL
a	NULL
key	NULL
regulatory	NULL
site	NULL
required	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
mediated	NULL
by	NULL
this	NULL
protein	NULL
(	NULL
Gonzalez	NULL
and	NULL
Montminy	NULL
,	NULL
1989	NULL
;	NULL
Sheng	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
THP1	NULL
monocytes	NULL
with	NULL
AB25-35	NULL
led	NULL
to	NULL
a	NULL
rapid	NULL
increase	NULL
in	NULL
CREB	NULL
phosphorylation	NULL
that	NULL
was	NULL
detectable	NULL
within	NULL
1	NULL
min	NULL
and	NULL
remained	NULL
elevated	NULL
through	NULL
10	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

74	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
J	NULL
.	NULL

Neurosci	NULL
.	NULL

,	NULL
June	NULL
15	NULL
,	NULL
1998	NULL
,	NULL
18	NULL
(	NULL
12	NULL
)	NULL
:4451-4460	NULL
4455	NULL
minutes	NULL
wap	NULL
www	NULL
»	NULL
D	NULL
AB	NULL
]	NULL
phospho-p38	NULL
Figure	NULL
3	NULL
.	NULL

Fibrillar	NULL
Af	NULL
stimulates	NULL
the	NULL
rapid	NULL
,	NULL
transient	NULL
activation	NULL
of	NULL
p38	NULL
MAPK	NULL
in	NULL
THP1	NULL
monocytes	NULL
and	NULL
microglia	NULL
.	NULL

4	NULL
,	NULL
THP1	NULL
monocytes	NULL
were	NULL
exposed	NULL
to	NULL
50	NULL
um	NULL
AB25-35	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
p38	NULL
MAPK	NULL
was	NULL
detected	NULL
using	NULL
anti-phospho-p38	NULL
antibody	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
reprobed	NULL
with	NULL
anti-p38	NULL
antibody	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Exposure	NULL
of	NULL
primary	NULL
cultures	NULL
of	NULL
rat	NULL
microglia	NULL
to	NULL
50	NULL
pm	NULL
AfB25-35	NULL
for	NULL
2	NULL
min	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
p38	NULL
MAPK	NULL
.	NULL

C	NULL
,	NULL
Ligand	NULL
specificity	NULL
of	NULL
p38	NULL
MAPK	NULL
activation	NULL
in	NULL
THP1	NULL
monocytes	NULL
.	NULL

THP1	NULL
monocytes	NULL
were	NULL
stimulated	NULL
with	NULL
50	NULL
um	NULL
AB25-35	NULL
or	NULL
20	NULL
ug/ml	NULL
AcLDL	NULL
,	NULL
mBSA	NULL
,	NULL
and	NULL
AGE-L	NULL
for	NULL
2	NULL
min	NULL
.	NULL

Activation	NULL
of	NULL
p38	NULL
MAPK	NULL
in	NULL
A-C	NULL
was	NULL
determined	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
on	NULL
RIPA	NULL
lysates	NULL
(	NULL
50	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
using	NULL
anti-phospho-p38	NULL
MAPK	NULL
polyclonal	NULL
antibodies	NULL
.	NULL

A.	NULL
DMSO	NULL
50	NULL
ug/ml	NULL
Piceat	NULL
.	NULL

0	NULL
2	NULL
0	NULL
2	NULL
minutes	NULL
Blot	NULL
:	NULL
ERK2	NULL
]	NULL
ait	NULL
-	NULL
pERK	NULL
B.	NULL
DMSO	NULL
50	NULL
ug/ml	NULL
Piceat	NULL
]	NULL
0	NULL
|	NULL
2	NULL
0	NULL
_|	NULL
2	NULL
|	NULL
minutes	NULL
WW	NULL
awn	NULL
th	NULL
|	NULL
=	NULL
<	NULL
phospho-p38	NULL
Figure	NULL
5	NULL
.	NULL

The	NULL
tyrosine	NULL
kinase	NULL
inhibitor	NULL
piceatannol	NULL
inhibits	NULL
AB-induced	NULL
activation	NULL
of	NULL
ERK	NULL
and	NULL
p38	NULL
MAPK	NULL
.	NULL

THP1	NULL
monocytes	NULL
were	NULL
pretreated	NULL
for	NULL
1	NULL
hr	NULL
with	NULL
50	NULL
pg/ml	NULL
piceatannol	NULL
or	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
DMSO	NULL
(	NULL
final	NULL
concentration	NULL
,	NULL
70	NULL
mm	NULL
)	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
50	NULL
um	NULL
AB25-35	NULL
for	NULL
2	NULL
min	NULL
.	NULL

4	NULL
,	NULL
Activation	NULL
of	NULL
ERK2	NULL
was	NULL
demonstrated	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
RIPA	NULL
lysates	NULL
(	NULL
50	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
using	NULL
anti-phospho-ERK	NULL
polyclonal	NULL
antibodies	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
reprobed	NULL
with	NULL
anti-ERK	NULL
antibody	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Activation	NULL
of	NULL
p38	NULL
MAPK	NULL
was	NULL
assessed	NULL
by	NULL
immunoprecipitation	NULL
of	NULL
tyrosine	NULL
phosphoproteins	NULL
using	NULL
monoclonal	NULL
anti-phosphotyrosine	NULL
antibodies	NULL
(	NULL
PY20	NULL
)	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
anti-phospho-p38	NULL
MAPK	NULL
antibodies	NULL
.	NULL

4456	NULL
J	NULL
.	NULL

Neurosci	NULL
.	NULL

,	NULL
June	NULL
15	NULL
,	NULL
1998	NULL
,	NULL
18	NULL
(	NULL
12	NULL
)	NULL
:4451-4460	NULL
McDonald	NULL
et	NULL
al	NULL
.	NULL

e	NULL
AB-Stimulated	NULL
Activation	NULL
of	NULL
MAP	NULL
Kinases	NULL
in	NULL
Microglia	NULL
A	NULL
.	NULL

B	NULL
.	NULL

100000	NULL
90000	NULL
-	NULL
4	NULL
$	NULL
0000	NULL
-	NULL
$	NULL
70000	NULL
-	NULL
|	NULL
60000	NULL
CPM	NULL
into	NULL
S6	NULL
CPM	NULL
into	NULL
S6	NULL
40000	NULL
+	NULL
30000	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
&	NULL
r	NULL
rry=	NULL
1	NULL
50000	NULL
40000	NULL
300007	NULL
CPM	NULL
into	NULL
S6	NULL
(	NULL
DMSO	NULL
)	NULL
200005	NULL
[	NULL
§	NULL
CPM	NULL
into	NULL
S6	NULL
(	NULL
PD98059	NULL
)	NULL
10000	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
DMSO	NULL
25	NULL
uM	NULL
PD	NULL
minutes	NULL
<	NULL
4-RSK2	NULL
4-	NULL
IgG	NULL
Figure	NULL
6	NULL
.	NULL

-	NULL
Fibrillar	NULL
Af	NULL
stimulates	NULL
rapid	NULL
,	NULL
transient	NULL
activation	NULL
of	NULL
RSK1	NULL
and	NULL
RSK2	NULL
in	NULL
THP1	NULL
monocytes	NULL
,	NULL
which	NULL
is	NULL
blocked	NULL
by	NULL
the	NULL
MEK	NULL
inhibitor	NULL
PD98059	NULL
.	NULL

THP1	NULL
monocytes	NULL
were	NULL
stimulated	NULL
with	NULL
50	NULL
um	NULL
AfB25-35	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

A	NULL
,	NULL
RSK1	NULL
was	NULL
isolated	NULL
by	NULL
immunoprecipitation	NULL
with	NULL
anti-RSK1	NULL
polyclonal	NULL
antibodies	NULL
,	NULL
and	NULL
immune	NULL
kinase	NULL
activity	NULL
was	NULL
measured	NULL
using	NULL
the	NULL
S6	NULL
peptide	NULL
substrate	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
triplicate	NULL
determinations	NULL
.	NULL

B	NULL
,	NULL
THP1	NULL
monocytes	NULL
were	NULL
pretreated	NULL
for	NULL
20	NULL
min	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
25	NULL
um	NULL
PD98059	NULL
followed	NULL
by	NULL
stimulation	NULL
for	NULL
2	NULL
min	NULL
with	NULL
50	NULL
um	NULL
AB25-35	NULL
.	NULL

RSK2	NULL
was	NULL
isolated	NULL
by	NULL
immunoprecipitation	NULL
with	NULL
anti-RSK2	NULL
polyclonal	NULL
antibodies	NULL
.	NULL

Kinase	NULL
activity	NULL
was	NULL
measured	NULL
using	NULL
S6	NULL
peptide	NULL
as	NULL
a	NULL
substrate	NULL
,	NULL
and	NULL
incorporation	NULL
of	NULL
°°P	NULL
was	NULL
determined	NULL
by	NULL
Cerenkov	NULL
counting	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
anti-RSK1	NULL
or	NULL
anti-RSK2	NULL
antibodies	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

stimulation	NULL
of	NULL
microglia	NULL
with	NULL
AB25-35	NULL
led	NULL
to	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
at	NULL
serine	NULL
133	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
we	NULL
consistently	NULL
have	NULL
observed	NULL
that	NULL
the	NULL
anti-phospho-CREB	NULL
antibody	NULL
recognizes	NULL
a	NULL
doublet	NULL
in	NULL
Western	NULL
blots	NULL
of	NULL
proteins	NULL
from	NULL
unstimulated	NULL
rat	NULL
microglia	NULL
,	NULL
but	NULL
not	NULL
from	NULL
human	NULL
THP1	NULL
monocytes	NULL
.	NULL

This	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
the	NULL
result	NULL
of	NULL
a	NULL
species-specific	NULL
difference	NULL
in	NULL
CREB	NULL
protein	NULL
or	NULL
may	NULL
represent	NULL
an	NULL
elevated	NULL
basal	NULL
level	NULL
of	NULL
activation	NULL
in	NULL
cultures	NULL
of	NULL
primary	NULL
microglia	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
dependence	NULL
of	NULL
CREB	NULL
phosphorylation	NULL
on	NULL
activation	NULL
of	NULL
tyrosine	NULL
kinases	NULL
in	NULL
AfB-stimulated	NULL
THP1	NULL
monocytes	NULL
,	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
piceatannol	NULL
.	NULL

Pretreatment	NULL
of	NULL
THP1	NULL
monocytes	NULL
with	NULL
piceatannol	NULL
completely	NULL
blocked	NULL
AB-induced	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
,	NULL
linking	NULL
activation	NULL
of	NULL
Syk	NULL
to	NULL
subsequent	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
CREB	NULL
phosphorylation	NULL
was	NULL
dependent	NULL
on	NULL
MEK	NULL
and	NULL
ERK	NULL
activation	NULL
as	NULL
pretreatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
PD98059	NULL
abolished	NULL
the	NULL
Af-stimulated	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
on	NULL
serine	NULL
133	NULL
(	NULL
Fig	NULL
.	NULL

7D	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
AB-stimulated	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
PD98059	NULL
,	NULL
demonstrating	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
drug	NULL
action	NULL
(	NULL
Fig	NULL
.	NULL

76	NULL
)	NULL
.	NULL

These	NULL
data	NULL
provide	NULL
a	NULL
mechanism	NULL
through	NULL
which	NULL
AfB-induced	NULL
,	NULL
tyrosine	NULL
kinase-dependent	NULL
activation	NULL
of	NULL
MAPK	NULL
pathways	NULL
in	NULL
THP1	NULL
monocytes	NULL
and	NULL
microglia	NULL
can	NULL
regulate	NULL
gene	NULL
expression	NULL
.	NULL

DISCUSSION	NULL
The	NULL
events	NULL
leading	NULL
to	NULL
neuronal	NULL
death	NULL
and	NULL
gliosis	NULL
in	NULL
Alzheimer	NULL
's	NULL
disease	NULL
are	NULL
incompletely	NULL
understood	NULL
.	NULL

Gliosis	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
mature	NULL
senile	NULL
plaques	NULL
comprising	NULL
fibrillar	NULL
AB	NULL
(	NULL
Ohgami	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Fibrillar	NULL
Af	NULL
,	NULL
which	NULL
forms	NULL
the	NULL
core	NULL
of	NULL
senile	NULL
plaques	NULL
,	NULL
is	NULL
capable	NULL
of	NULL
directly	NULL
activating	NULL
microglia	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
production	NULL
of	NULL
superoxide	NULL
radicals	NULL
(	NULL
El	NULL
Khoury	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
McDonald	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
examination	NULL
of	NULL
AD-afflicted	NULL
brain	NULL
tissue	NULL
has	NULL
revealed	NULL
evidence	NULL
of	NULL
oxidative	NULL
damage	NULL
associated	NULL
with	NULL
senile	NULL
plaques	NULL
that	NULL
colocalizes	NULL
with	NULL
reactive	NULL
microglia	NULL
(	NULL
Hensley	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Good	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Smith	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

However	NULL
,	NULL
examination	NULL
of	NULL
senile	NULL
plaques	NULL
has	NULL
also	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
cytokines	NULL
,	NULL
such	NULL
as	NULL
IL-1	NULL
and	NULL
IL-6	NULL
,	NULL
proteases	NULL
,	NULL
protease	NULL
inhibitors	NULL
,	NULL
and	NULL
complement	NULL
proteins	NULL
(	NULL
Abraham	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Griffin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
McGeer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Bauer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
senile	NULL
plaque	NULL
,	NULL
therefore	NULL
,	NULL
is	NULL
the	NULL
focus	NULL
of	NULL
complex	NULL
local	NULL
inflammatory	NULL
processes	NULL
.	NULL

Microglia	NULL
,	NULL
the	NULL
main	NULL
immune	NULL
effector	NULL
cells	NULL
within	NULL
the	NULL
brain	NULL
,	NULL
are	NULL
capable	NULL
of	NULL
secreting	NULL
acute	NULL
phase	NULL
proteins	NULL
detected	NULL
in	NULL
the	NULL
AD	NULL
brain	NULL
(	NULL
Leong	NULL
and	NULL
Ling	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
detection	NULL
of	NULL
microglial-derived	NULL
acute	NULL
phase	NULL
proteins	NULL
in	NULL
senile	NULL
plaques	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
microglia	NULL
to	NULL
detect	NULL
fibrillar	NULL
AB	NULL
,	NULL
leading	NULL
to	NULL
activation	NULL
of	NULL
signal	NULL
transduction	NULL
pathways	NULL
,	NULL
altered	NULL
gene	NULL
expression	NULL
,	NULL
and	NULL
McDonald	NULL
et	NULL
al	NULL
.	NULL

e	NULL
AB-Stimulated	NULL
Activation	NULL
of	NULL
MAP	NULL
Kinases	NULL
in	NULL
Microglia	NULL
J	NULL
.	NULL

Neurosci	NULL
.	NULL

,	NULL
June	NULL
15	NULL
,	NULL
1998	NULL
,	NULL
18	NULL
(	NULL
12	NULL
)	NULL
:4451-4460	NULL
4457	NULL
A	NULL
.	NULL

B	NULL
.	NULL

0	NULL
|	NULL
1	NULL
|	NULL
2	NULL
|	NULL
3	NULL
|	NULL
s	NULL
|	NULL
10	NULL
|	NULL
minutes	NULL
2	NULL
minutes	NULL
Blot	NULL
:	NULL
Blot	NULL
:	NULL
-	NULL
&	NULL
a	NULL
aim	NULL
a	NULL
io	NULL
t	NULL
ai	NULL
»	NULL
wm	NULL
w	NULL
#	NULL
)	NULL
pCREB	NULL
-	NULL
pCREB	NULL
@	NULL
e	NULL
@	NULL
e	NULL
@	NULL
8e8	NULL
@	NULL
00	NULL
@	NULL
0	NULL
@	NULL
8800|	NULL
CR=L	NULL
AHAD	NULL
|	NULL
CREB	NULL
C.	NULL
D.	NULL
E.	NULL
DMSO	NULL
_	NULL
|	NULL
50	NULL
pg/ml	NULL
Piceag	NULL
DMSO	NULL
|	NULL
25	NULL
MPD	NULL
DMSO	NULL
|	NULL
25	NULL
#	NULL
M	NULL
PD	NULL
]	NULL
0	NULL
|	NULL
2	NULL
|	NULL
0	NULL
|_	NULL
2	NULL
_|	NULL
minutes	NULL
W	NULL
2	NULL
0	NULL
2	NULL
|minutes	NULL
0	NULL
2	NULL
2	NULL
|	NULL
minutes	NULL
Blot	NULL
:	NULL
*I	NULL
!	NULL

Biot	NULL
,	NULL
Adt	NULL
-	NULL
»	NULL
~-	NULL
-as	NULL
|	NULL
pCREB	NULL
|	NULL
--	NULL
ame	NULL
w	NULL
|	NULL
pCREB	NULL
-103	NULL
kDa	NULL
stin	NULL
atime	NULL
auth	NULL
sta	NULL
|	NULL
CREE	NULL
E	NULL
diam	NULL
»	NULL
CREE	NULL
67	NULL
@	NULL
UB	NULL
46	NULL
Blot	NULL
:	NULL
Anti-phosphotyrosine	NULL
Figure	NULL
7	NULL
.	NULL

Fibrillar	NULL
AB	NULL
stimulates	NULL
rapid	NULL
,	NULL
transient	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
on	NULL
serine	NULL
133	NULL
in	NULL
THP1	NULL
monocytes	NULL
and	NULL
microglia	NULL
that	NULL
is	NULL
blocked	NULL
by	NULL
piceatannol	NULL
and	NULL
PD98059	NULL
.	NULL

4	NULL
,	NULL
THP1	NULL
monocytes	NULL
were	NULL
stimulated	NULL
with	NULL
50	NULL
um	NULL
AB25-35	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

B	NULL
,	NULL
Primary	NULL
cultures	NULL
of	NULL
rat	NULL
microglia	NULL
were	NULL
stimulated	NULL
with	NULL
50	NULL
um	NULL
AfB25-35	NULL
for	NULL
2	NULL
min	NULL
.	NULL

C	NULL
,	NULL
AB-induced	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
is	NULL
blocked	NULL
by	NULL
pretreatment	NULL
of	NULL
THP1	NULL
monocytes	NULL
with	NULL
piceatannol	NULL
.	NULL

THP1	NULL
monocytes	NULL
were	NULL
pretreated	NULL
with	NULL
50	NULL
ug/ml	NULL
piceatannol	NULL
or	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
DMSO	NULL
(	NULL
final	NULL
concentration	NULL
,	NULL
70	NULL
mm	NULL
)	NULL
for	NULL
1	NULL
hr	NULL
,	NULL
followed	NULL
by	NULL
stimulation	NULL
with	NULL
50	NULL
um	NULL
AB25-35	NULL
for	NULL
2	NULL
min	NULL
.	NULL

D	NULL
,	NULL
AB-induced	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
is	NULL
blocked	NULL
by	NULL
pretreatment	NULL
of	NULL
THP1	NULL
monocytes	NULL
with	NULL
PD98059	NULL
.	NULL

THP1	NULL
monocytes	NULL
were	NULL
pretreated	NULL
with	NULL
25	NULL
um	NULL
PD98059	NULL
or	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
DMSO	NULL
for	NULL
20	NULL
min	NULL
,	NULL
followed	NULL
by	NULL
stimulation	NULL
with	NULL
50	NULL
um	NULL
AfB25-35	NULL
for	NULL
2	NULL
min	NULL
.	NULL

Phosphorylation	NULL
of	NULL
CREB	NULL
in	NULL
4-D	NULL
was	NULL
determined	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
on	NULL
RIPA	NULL
lysates	NULL
(	NULL
100	NULL
pug	NULL
of	NULL
protein	NULL
)	NULL
using	NULL
anti-phospho-CREB	NULL
polyclonal	NULL
antibodies	NULL
(	NULL
fop	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
stripped	NULL
and	NULL
reprobed	NULL
using	NULL
anti-CREB	NULL
antibody	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

E	NULL
,	NULL
Pretreatment	NULL
of	NULL
THP1	NULL
monocytes	NULL
with	NULL
PD98059	NULL
does	NULL
not	NULL
inhibit	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

THP1	NULL
monocytes	NULL
were	NULL
pretreated	NULL
with	NULL
25	NULL
um	NULL
PD98059	NULL
or	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
DMSO	NULL
for	NULL
20	NULL
min	NULL
,	NULL
followed	NULL
by	NULL
stimulation	NULL
with	NULL
50	NULL
um	NULL
AB25-35	NULL
for	NULL
2	NULL
min	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
tyrosine	NULL
phosphoproteins	NULL
was	NULL
performed	NULL
on	NULL
RIPA	NULL
lysates	NULL
(	NULL
100	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
using	NULL
monoclonal	NULL
anti-phosphotyrosine	NULL
antibodies	NULL
(	NULL
4G10	NULL
)	NULL
.	NULL

acquisition	NULL
of	NULL
a	NULL
reactive	NULL
phenotype	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
exposure	NULL
of	NULL
microglia	NULL
and	NULL
THP1	NULL
monocytes	NULL
to	NULL
fibrillar	NULL
forms	NULL
of	NULL
AB	NULL
leads	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
tyrosine	NULL
kinases	NULL
Lyn	NULL
,	NULL
Syk	NULL
,	NULL
and	NULL
FAK	NULL
and	NULL
production	NULL
of	NULL
superoxide	NULL
.	NULL

The	NULL
present	NULL
studies	NULL
were	NULL
initiated	NULL
to	NULL
identify	NULL
the	NULL
downstream	NULL
intracellular	NULL
elements	NULL
mediating	NULL
the	NULL
effects	NULL
of	NULL
AB	NULL
on	NULL
these	NULL
cells	NULL
.	NULL

The	NULL
MAPK	NULL
family	NULL
of	NULL
protein	NULL
kinases	NULL
is	NULL
an	NULL
important	NULL
link	NULL
in	NULL
the	NULL
transduction	NULL
of	NULL
extracellular	NULL
signals	NULL
from	NULL
the	NULL
membrane	NULL
into	NULL
the	NULL
nucleus	NULL
.	NULL

ERK1	NULL
and	NULL
ERK2	NULL
are	NULL
positioned	NULL
downstream	NULL
of	NULL
growth	NULL
factor	NULL
receptors	NULL
in	NULL
ras-dependent	NULL
signal	NULL
transduction	NULL
cascades	NULL
,	NULL
which	NULL
include	NULL
raf	NULL
family	NULL
members	NULL
and	NULL
MEK	NULL
(	NULL
Blenis	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

On	NULL
phosphorylation	NULL
and	NULL
activation	NULL
,	NULL
ERKs	NULL
phosphorylate	NULL
other	NULL
cytoplasmic	NULL
effectors	NULL
and	NULL
are	NULL
translocated	NULL
into	NULL
the	NULL
nucleus	NULL
in	NULL
which	NULL
they	NULL
phosphorylate	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
Myc	NULL
,	NULL
Fos	NULL
,	NULL
Jun	NULL
,	NULL
and	NULL
Elk1	NULL
(	NULL
Blenis	NULL
,	NULL
1993	NULL
;	NULL
Chen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Direct	NULL
substrates	NULL
of	NULL
the	NULL
ERKs	NULL
include	NULL
two	NULL
members	NULL
of	NULL
the	NULL
RSK	NULL
family	NULL
of	NULL
protein	NULL
serine-threonine	NULL
kinases	NULL
,	NULL
RSK1	NULL
and	NULL
RSK2	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
CREB	NULL
is	NULL
phosphorylated	NULL
on	NULL
serine	NULL
133	NULL
in	NULL
vivo	NULL
by	NULL
RSK2	NULL
in	NULL
NGF-stimulated	NULL
PC12	NULL
cells	NULL
(	NULL
Xing	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
stimulation	NULL
of	NULL
microglia	NULL
and	NULL
THP1	NULL
monocytes	NULL
with	NULL
fibrillar	NULL
AB	NULL
peptides	NULL
led	NULL
to	NULL
activation	NULL
of	NULL
ERK1	NULL
,	NULL
ERK2	NULL
,	NULL
RSK1	NULL
,	NULL
and	NULL
RSK2	NULL
and	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
on	NULL
serine	NULL
133	NULL
.	NULL

Importantly	NULL
,	NULL
Af	NULL
induced	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
was	NULL
inhibited	NULL
by	NULL
piceatannol	NULL
and	NULL
the	NULL
MEK	NULL
inhibitor	NULL
PD98059	NULL
,	NULL
demonstrating	NULL
the	NULL
dependence	NULL
of	NULL
CREB	NULL
phosphorylation	NULL
on	NULL
activation	NULL
of	NULL
the	NULL
ERK	NULL
pathway	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
other	NULL
kinases	NULL
,	NULL
such	NULL
as	NULL
protein	NULL
kinase	NULL
A	NULL
or	NULL
CAM	NULL
kinases	NULL
(	NULL
Gonzalez	NULL
and	NULL
Montminy	NULL
,	NULL
1989	NULL
;	NULL
Sheng	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
may	NULL
also	NULL
contribute	NULL
to	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
in	NULL
response	NULL
to	NULL
AB	NULL
and	NULL
other	NULL
ligands	NULL
.	NULL

The	NULL
complete	NULL
inhibition	NULL
of	NULL
CREB	NULL
phosphorylation	NULL
by	NULL
PD98059	NULL
,	NULL
however	NULL
,	NULL
suggests	NULL
that	NULL
the	NULL
ERK	NULL
pathway	NULL
is	NULL
the	NULL
main	NULL
signaling	NULL
pathway	NULL
leading	NULL
to	NULL
transcriptional	NULL
activation	NULL
through	NULL
CREB	NULL
in	NULL
AfB-stimulated	NULL
monocytic	NULL
cells	NULL
.	NULL

The	NULL
present	NULL
data	NULL
provide	NULL
a	NULL
mechanism	NULL
by	NULL
which	NULL
Af	NULL
alters	NULL
gene	NULL
expression	NULL
through	NULL
the	NULL
transcription	NULL
factor	NULL
CREB	NULL
.	NULL

Importantly	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
compounds	NULL
that	NULL
block	NULL
AfB-stimulated	NULL
intracellular	NULL
signaling	NULL
cascades	NULL
in	NULL
microglia	NULL
may	NULL
block	NULL
changes	NULL
in	NULL
gene	NULL
expression	NULL
and	NULL
,	NULL
hence	NULL
,	NULL
the	NULL
acquisition	NULL
of	NULL
an	NULL
activated	NULL
phenotype	NULL
.	NULL

Stimulation	NULL
of	NULL
B	NULL
lymphocytes	NULL
through	NULL
surface	NULL
Ig	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
result	NULL
in	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
,	NULL
demonstrating	NULL
a	NULL
role	NULL
for	NULL
activation	NULL
of	NULL
CREB	NULL
in	NULL
response	NULL
to	NULL
immune	NULL
stimuli	NULL
(	NULL
Xie	NULL
and	NULL
Rothstein	NULL
,	NULL
1995	NULL
;	NULL
Xie	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Cytokines	NULL
,	NULL
such	NULL
as	NULL
IL-18	NULL
and	NULL
IL-6	NULL
,	NULL
have	NULL
been	NULL
detected	NULL
within	NULL
senile	NULL
plaques	NULL
,	NULL
and	NULL
total	NULL
IL-1	NULL
$	NULL
levels	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
elevated	NULL
in	NULL
the	NULL
AD	NULL
brain	NULL
(	NULL
Griffin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Bauer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Stimu-	NULL
4458	NULL
J	NULL
.	NULL

Neurosci	NULL
.	NULL

,	NULL
June	NULL
15	NULL
,	NULL
1998	NULL
,	NULL
18	NULL
(	NULL
12	NULL
)	NULL
:4451-4460	NULL
AB-stimulated	NULL
Signaling	NULL
Cascades	NULL
in	NULL
Microglia	NULL
and	NULL
Monocytic	NULL
Cells	NULL
Putative	NULL
AB	NULL
Receptor	NULL
AB	NULL
Plague	NULL
___	NULL
Receptor	NULL
Clustering	NULL
9	NULL
s	NULL
Respiratory	NULL
Burst	NULL
-	NULL
O	NULL
;	NULL
is	NULL
f	NULL
:	NULL
Nucleus	NULL
$	NULL
IL1B/TNFoa/complement	NULL
Figure	NULL
8	NULL
.	NULL

Working	NULL
model	NULL
of	NULL
AfB-induced	NULL
intracellular	NULL
signal	NULL
transduction	NULL
cascades	NULL
in	NULL
microglia	NULL
and	NULL
monocytic	NULL
cells	NULL
.	NULL

On	NULL
interaction	NULL
of	NULL
microglia	NULL
with	NULL
fibrillar	NULL
aggregates	NULL
of	NULL
Af	NULL
,	NULL
a	NULL
complex	NULL
signal	NULL
transduction	NULL
cascade	NULL
comprising	NULL
tyrosine	NULL
kinases	NULL
and	NULL
parallel	NULL
MAP	NULL
kinase	NULL
pathways	NULL
is	NULL
activated	NULL
,	NULL
leading	NULL
to	NULL
respiratory	NULL
burst	NULL
and	NULL
activation	NULL
of	NULL
transcription	NULL
.	NULL

The	NULL
generation	NULL
of	NULL
superoxide	NULL
radicals	NULL
,	NULL
cytokines	NULL
,	NULL
and	NULL
complement	NULL
components	NULL
is	NULL
likely	NULL
to	NULL
further	NULL
stimulate	NULL
inflammatory	NULL
responses	NULL
in	NULL
microglia	NULL
.	NULL

An	NULL
asterisk	NULL
denotes	NULL
phosphorylation	NULL
and/or	NULL
activation	NULL
of	NULL
enzymatic	NULL
activity	NULL
.	NULL

lation	NULL
of	NULL
microglia	NULL
and	NULL
THP1	NULL
monocytes	NULL
with	NULL
AB	NULL
resulted	NULL
in	NULL
increased	NULL
expression	NULL
of	NULL
IL-1	NULL
(	NULL
Walker	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Lorton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
activation	NULL
of	NULL
p38	NULL
MAPK	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
the	NULL
LPS-induced	NULL
production	NULL
of	NULL
IL-18	NULL
in	NULL
monocytes	NULL
,	NULL
as	NULL
well	NULL
as	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
MEFC2	NULL
(	NULL
Lee	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Han	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
exposure	NULL
of	NULL
cells	NULL
to	NULL
IL-1	NULL
,	NULL
stress	NULL
,	NULL
and	NULL
heat	NULL
shock	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
MAPKAP	NULL
kinase-2	NULL
and	NULL
MAPKAP	NULL
kinase-3	NULL
,	NULL
which	NULL
are	NULL
direct	NULL
effectors	NULL
of	NULL
p38	NULL
MAPK	NULL
(	NULL
Rouse	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
McLaughlin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

MAPKAP	NULL
kinase-2	NULL
and	NULL
MAPKAP	NULL
kinase-3	NULL
then	NULL
phosphorylate	NULL
the	NULL
small	NULL
heat	NULL
shock	NULL
protein	NULL
HSP27	NULL
in	NULL
vivo	NULL
(	NULL
McLaughlin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Stokoe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992b	NULL
)	NULL
.	NULL

We	NULL
have	NULL
now	NULL
shown	NULL
that	NULL
stimulation	NULL
of	NULL
microglia	NULL
and	NULL
THP1	NULL
monocytes	NULL
with	NULL
AB	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
p38	NULL
MAPK	NULL
,	NULL
providing	NULL
a	NULL
mechanistic	NULL
link	NULL
between	NULL
the	NULL
interaction	NULL
of	NULL
microglia	NULL
with	NULL
AB	NULL
and	NULL
inflammatory	NULL
responses	NULL
,	NULL
including	NULL
activation	NULL
of	NULL
downstream	NULL
kinases	NULL
and	NULL
transcription	NULL
factors	NULL
and	NULL
the	NULL
elevated	NULL
levels	NULL
of	NULL
cytokines	NULL
found	NULL
in	NULL
the	NULL
AD	NULL
brain	NULL
.	NULL

IL-1	NULL
$	NULL
,	NULL
a	NULL
proinfiam-matory	NULL
cytokine	NULL
that	NULL
primes	NULL
macrophage	NULL
inflammatory	NULL
responses	NULL
and	NULL
enhances	NULL
macrophage	NULL
cytotoxicity	NULL
,	NULL
recently	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
p38	NULL
MAPK	NULL
(	NULL
Erbe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Simms	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Raingeaud	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
activation	NULL
of	NULL
p38	NULL
MAPK	NULL
in	NULL
microglia	NULL
by	NULL
AB	NULL
may	NULL
be	NULL
an	NULL
initial	NULL
step	NULL
in	NULL
a	NULL
feedforward	NULL
inflammatory	NULL
process	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
production	NULL
of	NULL
superoxide	NULL
radicals	NULL
and	NULL
cytokines	NULL
,	NULL
which	NULL
further	NULL
stimulates	NULL
the	NULL
inflammatory	NULL
responses	NULL
of	NULL
microglia	NULL
to	NULL
Af	NULL
.	NULL

A	NULL
working	NULL
model	NULL
of	NULL
the	NULL
intracellular	NULL
processes	NULL
activated	NULL
on	NULL
interaction	NULL
of	NULL
microglia	NULL
with	NULL
AB	NULL
plaques	NULL
is	NULL
diagrammed	NULL
in	NULL
Figure	NULL
8	NULL
.	NULL

We	NULL
were	NULL
unable	NULL
to	NULL
detect	NULL
significant	NULL
increases	NULL
in	NULL
SAPK	NULL
activity	NULL
from	NULL
AB-stimulated	NULL
THP1	NULL
monocytes	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
p38	NULL
MAPK	NULL
and	NULL
SAPKs	NULL
by	NULL
environmental	NULL
stressors	NULL
and	NULL
immune	NULL
McDonald	NULL
et	NULL
al	NULL
.	NULL

e	NULL
AB-Stimulated	NULL
Activation	NULL
of	NULL
MAP	NULL
Kinases	NULL
in	NULL
Microglia	NULL
stimuli	NULL
is	NULL
thought	NULL
to	NULL
occur	NULL
in	NULL
parallel	NULL
,	NULL
and	NULL
previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
SAPK	NULL
and	NULL
p38	NULL
MAPK	NULL
are	NULL
activated	NULL
simultaneously	NULL
(	NULL
Raingeaud	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
present	NULL
data	NULL
clearly	NULL
document	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
p38	NULL
MAPK	NULL
and	NULL
SAPK	NULL
activation	NULL
are	NULL
not	NULL
mechanistically	NULL
linked	NULL
,	NULL
and	NULL
AB	NULL
stimulation	NULL
selectively	NULL
activates	NULL
the	NULL
p38	NULL
MAPK	NULL
pathway	NULL
.	NULL

The	NULL
upstream	NULL
elements	NULL
mediating	NULL
these	NULL
responses	NULL
have	NULL
not	NULL
yet	NULL
been	NULL
defined	NULL
and	NULL
are	NULL
presently	NULL
controversial	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
upstream	NULL
regulators	NULL
of	NULL
ERKs	NULL
and	NULL
p38	NULL
MAPK	NULL
activated	NULL
by	NULL
Af	NULL
will	NULL
allow	NULL
further	NULL
elucidation	NULL
of	NULL
the	NULL
components	NULL
of	NULL
MAPK	NULL
signal	NULL
transduction	NULL
pathways	NULL
and	NULL
provide	NULL
potential	NULL
therapeutic	NULL
targets	NULL
.	NULL

Recent	NULL
data	NULL
have	NULL
shown	NULL
that	NULL
AB	NULL
can	NULL
bind	NULL
RAGE	NULL
and	NULL
scavenger	NULL
receptors	NULL
(	NULL
El	NULL
K	NULL
houry	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Paresce	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Yan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

RAGE	NULL
is	NULL
believed	NULL
to	NULL
act	NULL
as	NULL
a	NULL
tether	NULL
that	NULL
binds	NULL
AB	NULL
to	NULL
cell	NULL
surfaces	NULL
in	NULL
which	NULL
AB-generated	NULL
oxygen	NULL
radicals	NULL
then	NULL
produce	NULL
cellular	NULL
damage	NULL
(	NULL
Hensley	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

There	NULL
is	NULL
presently	NULL
no	NULL
compelling	NULL
evidence	NULL
that	NULL
RAGE	NULL
is	NULL
directly	NULL
linked	NULL
to	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
.	NULL

Scavenger	NULL
receptors	NULL
were	NULL
shown	NULL
to	NULL
mediate	NULL
adhesion	NULL
of	NULL
microglia	NULL
to	NULL
Af	NULL
,	NULL
resulting	NULL
in	NULL
production	NULL
of	NULL
oxygen	NULL
radicals	NULL
by	NULL
microglial	NULL
cell	NULL
lines	NULL
(	NULL
El	NULL
Khoury	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
cellular	NULL
mechanisms	NULL
used	NULL
by	NULL
these	NULL
receptors	NULL
to	NULL
stimulate	NULL
the	NULL
generation	NULL
of	NULL
reactive	NULL
oxygen	NULL
species	NULL
are	NULL
unknown	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
specific	NULL
,	NULL
saturating	NULL
quantities	NULL
of	NULL
RAGE	NULL
and	NULL
scavenger	NULL
receptor	NULL
ligands	NULL
do	NULL
not	NULL
stimulate	NULL
the	NULL
increased	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
respiratory	NULL
burst	NULL
observed	NULL
after	NULL
exposure	NULL
of	NULL
THP1	NULL
monocytes	NULL
to	NULL
AB	NULL
(	NULL
McDonald	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
present	NULL
data	NULL
demonstrate	NULL
that	NULL
RAGE	NULL
and	NULL
scavenger	NULL
receptor	NULL
ligands	NULL
do	NULL
not	NULL
activate	NULL
ERK	NULL
or	NULL
p38	NULL
MAPK	NULL
in	NULL
THP1	NULL
monocytes	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
activation	NULL
of	NULL
tyrosine	NULL
kinases	NULL
,	NULL
ERK	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
by	NULL
scavenger	NULL
receptor	NULL
ligands	NULL
is	NULL
not	NULL
surprising	NULL
,	NULL
because	NULL
undifferentiated	NULL
THP1	NULL
monocytes	NULL
express	NULL
only	NULL
low	NULL
levels	NULL
of	NULL
scavenger	NULL
receptors	NULL
(	NULL
Palkama	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
observations	NULL
that	NULL
Af	NULL
fibrils	NULL
activate	NULL
tyrosine	NULL
kinases	NULL
,	NULL
MAP	NULL
kinase	NULL
pathways	NULL
,	NULL
respiratory	NULL
burst	NULL
,	NULL
and	NULL
transcription	NULL
factors	NULL
demonstrate	NULL
that	NULL
Af	NULL
stimulates	NULL
cellular	NULL
responses	NULL
through	NULL
a	NULL
receptor	NULL
complex	NULL
distinct	NULL
from	NULL
scavenger	NULL
receptors	NULL
and	NULL
RAGE	NULL
.	NULL

Furthermore	NULL
,	NULL
characterization	NULL
of	NULL
the	NULL
AB-stimulated	NULL
signaling	NULL
pathways	NULL
in	NULL
microglia	NULL
and	NULL
THP1	NULL
monocytes	NULL
may	NULL
provide	NULL
more	NULL
molecular	NULL
targets	NULL
for	NULL
therapeutic	NULL
interventions	NULL
as	NULL
well	NULL
as	NULL
specific	NULL
,	NULL
rapid	NULL
assays	NULL
for	NULL
testing	NULL
the	NULL
efficacy	NULL
of	NULL
therapeutic	NULL
agents	NULL
.	NULL

REFERENCES	NULL
Abraham	NULL
CR	NULL
,	NULL
Selkoe	NULL
DJ	NULL
,	NULL
Potter	NULL
H	NULL
(	NULL
1988	NULL
)	NULL
Immunochemical	NULL
identification	NULL
of	NULL
the	NULL
serine	NULL
protease	NULL
inhibitor	NULL
a	NULL
;	NULL
-antichymotrypsin	NULL
in	NULL
the	NULL
brain	NULL
amyloid	NULL
deposits	NULL
of	NULL
Alzheimer	NULL
's	NULL
disease	NULL
.	NULL

Cell	NULL
52:487-501	NULL
.	NULL

Bauer	NULL
J	NULL
,	NULL
Strauss	NULL
S	NULL
,	NULL
Schreiter-Gasser	NULL
U	NULL
,	NULL
Ganter	NULL
U	NULL
,	NULL
Schlegel	NULL
P	NULL
,	NULL
Witt	NULL
I	NULL
,	NULL
Yolk	NULL
B	NULL
,	NULL
Berger	NULL
M	NULL
(	NULL
1991	NULL
)	NULL
Interleukin-6	NULL
and	NULL
alpha-2-macroglobulin	NULL
indicate	NULL
an	NULL
acute	NULL
phase	NULL
in	NULL
Alzheimer	NULL
's	NULL
disease	NULL
cortices	NULL
FEBS	NULL
Lett	NULL
285:111-114	NULL
.	NULL

Blenis	NULL
J	NULL
(	NULL
1993	NULL
)	NULL
Signal	NULL
transduction	NULL
via	NULL
the	NULL
MAP	NULL
kinases	NULL
:	NULL
proceed	NULL
at	NULL
your	NULL
own	NULL
RSK	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:5889-5892	NULL
.	NULL

Boland	NULL
K	NULL
,	NULL
Behrens	NULL
M	NULL
,	NULL
Choi	NULL
D	NULL
,	NULL
Manias	NULL
K	NULL
,	NULL
Perlmutter	NULL
DH	NULL
(	NULL
1996	NULL
)	NULL
The	NULL
serpin	NULL
enzyme	NULL
complex	NULL
receptor	NULL
recognizes	NULL
soluble	NULL
,	NULL
nontoxic	NULL
amyloid-	NULL
peptide	NULL
but	NULL
not	NULL
aggregated	NULL
,	NULL
cytotoxic	NULL
amyloid-B	NULL
peptide	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
271:18032-18044	NULL
.	NULL

Bradford	NULL
MM	NULL
(	NULL
1976	NULL
)	NULL
A	NULL
rapid	NULL
and	NULL
sensitive	NULL
method	NULL
for	NULL
the	NULL
quantitation	NULL
of	NULL
microgram	NULL
quantities	NULL
of	NULL
protein	NULL
utilizing	NULL
the	NULL
principle	NULL
of	NULL
protein-dye	NULL
binding	NULL
.	NULL

Anal	NULL
Biochem	NULL
72:248-254	NULL
.	NULL

Cano	NULL
E	NULL
,	NULL
Mahadevan	NULL
LC	NULL
(	NULL
1995	NULL
)	NULL
Parallel	NULL
signal	NULL
processing	NULL
among	NULL
mammalian	NULL
MAPKs	NULL
.	NULL

Trends	NULL
Biochem	NULL
Sci	NULL
20:117-122	NULL
.	NULL

Cataldo	NULL
AM	NULL
,	NULL
Nixon	NULL
RA	NULL
(	NULL
1990	NULL
)	NULL
Enzymatically	NULL
active	NULL
lysosomal	NULL
pro-teases	NULL
are	NULL
associated	NULL
with	NULL
amyloid	NULL
deposits	NULL
in	NULL
Alzheimer	NULL
brain	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
87:3861-3865	NULL
.	NULL

Chen	NULL
R	NULL
,	NULL
Abate	NULL
C	NULL
,	NULL
Blenis	NULL
J	NULL
(	NULL
1993	NULL
)	NULL
Phosphorylation	NULL
of	NULL
the	NULL
c-Fos	NULL
transre-	NULL
McDonald	NULL
et	NULL
al	NULL
.	NULL

e	NULL
AB-Stimulated	NULL
Activation	NULL
of	NULL
MAP	NULL
Kinases	NULL
in	NULL
Microglia	NULL
pressive	NULL
domain	NULL
by	NULL
mitogen	NULL
activated	NULL
kinase	NULL
and	NULL
p90	NULL
ribosomal	NULL
S6	NULL
kinase	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:10952-10956	NULL
.	NULL

Dudley	NULL
DT	NULL
,	NULL
Pang	NULL
L	NULL
,	NULL
Decker	NULL
SJ	NULL
,	NULL
Bridges	NULL
AJ	NULL
,	NULL
Saltiel	NULL
AR	NULL
(	NULL
1995	NULL
)	NULL
A	NULL
synthetic	NULL
inhibitor	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
cascade	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
92:7686-7689	NULL
.	NULL

Durden	NULL
DL	NULL
,	NULL
Kim	NULL
HM	NULL
,	NULL
Calore	NULL
B	NULL
,	NULL
Liu	NULL
Y	NULL
(	NULL
1995	NULL
)	NULL
The	NULL
FoyRI	NULL
receptor	NULL
signal	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
hck	NULL
and	NULL
MAP	NULL
kinase	NULL
.	NULL

J	NULL
Immunol	NULL
154:4039-4047	NULL
.	NULL

El	NULL
Khoury	NULL
J	NULL
,	NULL
Hickman	NULL
SE	NULL
,	NULL
Thomas	NULL
CA	NULL
,	NULL
Cao	NULL
L	NULL
,	NULL
Silverstein	NULL
SC	NULL
,	NULL
Loike	NULL
JD	NULL
(	NULL
1996	NULL
)	NULL
Scavenger	NULL
receptor-mediated	NULL
adhesion	NULL
of	NULL
microglia	NULL
to	NULL
B-amyloid	NULL
fibrils	NULL
.	NULL

Nature	NULL
382:716-719	NULL
.	NULL

Erbe	NULL
DV	NULL
,	NULL
Collins	NULL
JE	NULL
,	NULL
Shen	NULL
L	NULL
,	NULL
Graziano	NULL
RF	NULL
,	NULL
Fanger	NULL
MW	NULL
(	NULL
1990	NULL
)	NULL
The	NULL
effect	NULL
of	NULL
cytokines	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
and	NULL
function	NULL
of	NULL
Fc	NULL
receptors	NULL
for	NULL
IgG	NULL
on	NULL
human	NULL
myeloid	NULL
cells	NULL
.	NULL

Mol	NULL
Immunol	NULL
27:57-67	NULL
.	NULL

Foltz	NULL
IN	NULL
,	NULL
Lee	NULL
JC	NULL
,	NULL
Young	NULL
PR	NULL
,	NULL
Schrader	NULL
JW	NULL
(	NULL
1997	NULL
)	NULL
Hematopoietic	NULL
growth	NULL
factors	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
IL-4	NULL
activate	NULL
the	NULL
p38	NULL
Mitogen-activated	NULL
protein	NULL
kinase	NULL
pathway	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
272:3296-3301	NULL
.	NULL

Freshney	NULL
NW	NULL
,	NULL
Rawlinson	NULL
L	NULL
,	NULL
Guesdon	NULL
F	NULL
,	NULL
Jones	NULL
E	NULL
,	NULL
Cowley	NULL
S	NULL
,	NULL
Hsuan	NULL
J	NULL
,	NULL
Saklatvala	NULL
J	NULL
(	NULL
1994	NULL
)	NULL
Interleukin-1	NULL
activates	NULL
a	NULL
novel	NULL
protein	NULL
kinase	NULL
cascade	NULL
that	NULL
results	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
Hsp27	NULL
.	NULL

Cell	NULL
78	NULL
:	NULL
1039-1049	NULL
.	NULL

Gille	NULL
H	NULL
,	NULL
Sharrocks	NULL
A	NULL
,	NULL
Shaw	NULL
P	NULL
(	NULL
1992	NULL
)	NULL
Phosphorylation	NULL
of	NULL
transcription	NULL
factor	NULL
p62tcf	NULL
by	NULL
MAP	NULL
kinase	NULL
stimulates	NULL
ternary	NULL
complex	NULL
formation	NULL
at	NULL
the	NULL
c-fos	NULL
promoter	NULL
.	NULL

Nature	NULL
358:414-417	NULL
.	NULL

Ginty	NULL
DD	NULL
,	NULL
Bonni	NULL
A	NULL
,	NULL
Greenberg	NULL
MA	NULL
(	NULL
1994	NULL
)	NULL
Nerve	NULL
growth	NULL
factor	NULL
activates	NULL
a	NULL
Ras-dependent	NULL
protein	NULL
kinase	NULL
that	NULL
stimulates	NULL
c-fos	NULL
transcription	NULL
via	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
.	NULL

Cell	NULL
77:713-725	NULL
.	NULL

Giulian	NULL
D	NULL
,	NULL
Baker	NULL
TJ	NULL
(	NULL
1986	NULL
)	NULL
Characterization	NULL
of	NULL
ameboid	NULL
microglia	NULL
isolated	NULL
from	NULL
developing	NULL
mammalian	NULL
brain	NULL
.	NULL

J	NULL
Neurosci	NULL
6:2163-2178	NULL
.	NULL

Glenner	NULL
GC	NULL
,	NULL
Wong	NULL
CW	NULL
(	NULL
1984	NULL
)	NULL
Initial	NULL
report	NULL
of	NULL
the	NULL
purification	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
novel	NULL
cerebrovascular	NULL
amyloid	NULL
protein	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
120:885-890	NULL
.	NULL

Gonzalez	NULL
GA	NULL
,	NULL
Montminy	NULL
MR	NULL
(	NULL
1989	NULL
)	NULL
Cyclic	NULL
AMP	NULL
stimulates	NULL
somatosta-tin	NULL
gene	NULL
transcription	NULL
by	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
at	NULL
serine	NULL
133	NULL
.	NULL

Cell	NULL
59:675-680	NULL
.	NULL

Good	NULL
PF	NULL
,	NULL
Werner	NULL
P	NULL
,	NULL
Hsu	NULL
A	NULL
,	NULL
Olanow	NULL
CW	NULL
,	NULL
Perl	NULL
DP	NULL
(	NULL
1996	NULL
)	NULL
Evidence	NULL
for	NULL
neuronal	NULL
oxidative	NULL
damage	NULL
in	NULL
Alzheimer	NULL
's	NULL
disease	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
149:21-28	NULL
.	NULL

Griffin	NULL
W	NULL
,	NULL
Stanley	NULL
L	NULL
,	NULL
Ling	NULL
C	NULL
(	NULL
1989	NULL
)	NULL
Brain	NULL
interleukin	NULL
1	NULL
and	NULL
S-100	NULL
im-munoreactivity	NULL
are	NULL
elevated	NULL
in	NULL
Down	NULL
's	NULL
syndrome	NULL
and	NULL
Alzheimer	NULL
's	NULL
disease	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:7611-7615	NULL
.	NULL

Grove	NULL
JR	NULL
,	NULL
Price	NULL
DJ	NULL
,	NULL
Banerjee	NULL
P	NULL
,	NULL
Balaubramanyam	NULL
A	NULL
,	NULL
Ahmad	NULL
MF	NULL
,	NULL
Avruch	NULL
J	NULL
(	NULL
1993	NULL
)	NULL
Regulation	NULL
of	NULL
an	NULL
epitope-tagged	NULL
recombinant	NULL
Rsk-1	NULL
S6	NULL
kinase	NULL
by	NULL
phorbol	NULL
ester	NULL
and	NULL
erk/MAP	NULL
kinase	NULL
.	NULL

Biochemistry	NULL
32:7727-7738	NULL
.	NULL

Haberland	NULL
ME	NULL
,	NULL
Fogelman	NULL
AM	NULL
(	NULL
1985	NULL
)	NULL
Scavenger	NULL
receptor-mediated	NULL
recognition	NULL
of	NULL
maleylbovine	NULL
plasma	NULL
albumin	NULL
and	NULL
the	NULL
demaleylated	NULL
protein	NULL
in	NULL
human	NULL
monocyte	NULL
macrophages	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
82:2693-2697	NULL
.	NULL

Han	NULL
J	NULL
,	NULL
Lee	NULL
J-D	NULL
,	NULL
Bibbs	NULL
L	NULL
,	NULL
Ulevitch	NULL
RJ	NULL
(	NULL
1994	NULL
)	NULL
A	NULL
MAP	NULL
kinase	NULL
targeted	NULL
by	NULL
endotoxin	NULL
and	NULL
hyperosmolarity	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Science	NULL
808-811	NULL
.	NULL

Han	NULL
J	NULL
,	NULL
Jiang	NULL
Y	NULL
,	NULL
Li	NULL
Z	NULL
,	NULL
Kravchenko	NULL
VV	NULL
,	NULL
Ulevitch	NULL
RJ	NULL
(	NULL
1997	NULL
)	NULL
Activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
MEF2C	NULL
by	NULL
the	NULL
MAP	NULL
kinase	NULL
p38	NULL
in	NULL
inflamma-tion	NULL
.	NULL

Nature	NULL
386:296-299	NULL
.	NULL

Hensley	NULL
K	NULL
,	NULL
Carney	NULL
JM	NULL
,	NULL
Mattson	NULL
MP	NULL
,	NULL
Aksenova	NULL
M	NULL
,	NULL
Harris	NULL
M	NULL
,	NULL
Wu	NULL
JF	NULL
,	NULL
Floyd	NULL
RA	NULL
,	NULL
Butterfield	NULL
DA	NULL
(	NULL
1994	NULL
)	NULL
A	NULL
model	NULL
for	NULL
B-amyloid	NULL
aggregation	NULL
and	NULL
neurotoxicity	NULL
based	NULL
on	NULL
free	NULL
radical	NULL
generation	NULL
by	NULL
the	NULL
peptide	NULL
:	NULL
relevance	NULL
to	NULL
Alzheimer	NULL
's	NULL
disease	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
91:3270-3274	NULL
.	NULL

Hensley	NULL
K	NULL
,	NULL
Lee	NULL
JC	NULL
,	NULL
Laydon	NULL
JT	NULL
,	NULL
McDonnell	NULL
PC	NULL
,	NULL
Gallagher	NULL
TF	NULL
,	NULL
Kumar	NULL
S	NULL
,	NULL
Green	NULL
D	NULL
,	NULL
McNulty	NULL
D	NULL
,	NULL
Blumenthal	NULL
MJ	NULL
,	NULL
Heys	NULL
JR	NULL
,	NULL
Landvatter	NULL
SW	NULL
,	NULL
Strickler	NULL
JE	NULL
,	NULL
McLaughlin	NULL
MM	NULL
,	NULL
Siemens	NULL
IR	NULL
,	NULL
Fisher	NULL
SM	NULL
,	NULL
Livi	NULL
GP	NULL
,	NULL
White	NULL
JR	NULL
,	NULL
Adams	NULL
JL	NULL
,	NULL
Young	NULL
PR	NULL
(	NULL
1995	NULL
)	NULL
Brain	NULL
regional	NULL
correspondence	NULL
between	NULL
Alzheimer	NULL
's	NULL
disease	NULL
histopathology	NULL
and	NULL
biomarkers	NULL
of	NULL
protein	NULL
oxidation	NULL
.	NULL

J	NULL
Neurochem	NULL
65:2146-2156	NULL
.	NULL

Itagaki	NULL
S	NULL
,	NULL
McGeer	NULL
PL	NULL
,	NULL
Akiyama	NULL
H	NULL
,	NULL
Zhu	NULL
S	NULL
,	NULL
Selkoe	NULL
D	NULL
(	NULL
1989	NULL
)	NULL
Relationship	NULL
of	NULL
microglia	NULL
and	NULL
astrocytes	NULL
to	NULL
amyloid	NULL
deposits	NULL
of	NULL
Alzheimer	NULL
's	NULL
disease	NULL
.	NULL

J	NULL
Neuroimmunol	NULL
24:173-182	NULL
.	NULL

Jao	NULL
S-C	NULL
,	NULL
Ma	NULL
J	NULL
,	NULL
Talafous	NULL
J	NULL
,	NULL
Orlando	NULL
R	NULL
,	NULL
Zagorski	NULL
MG	NULL
(	NULL
1997	NULL
)	NULL
Trifluoro-acetic	NULL
acid	NULL
pretreatment	NULL
reproducibly	NULL
disaggregates	NULL
the	NULL
amyloid	NULL
B-peptide	NULL
.	NULL

Amyloid	NULL
Int	NULL
J	NULL
Exp	NULL
Clin	NULL
Invest	NULL
4:240-252	NULL
.	NULL

Lee	NULL
JC	NULL
,	NULL
Hensley	NULL
K	NULL
,	NULL
Hall	NULL
N	NULL
,	NULL
Subramaniam	NULL
R	NULL
,	NULL
Cole	NULL
P	NULL
,	NULL
Harris	NULL
M	NULL
,	NULL
Aksenov	NULL
M	NULL
,	NULL
Aksenova	NULL
M	NULL
,	NULL
Gobbita	NULL
SP	NULL
,	NULL
Wu	NULL
JF	NULL
,	NULL
Carney	NULL
JM	NULL
,	NULL
Lovell	NULL
M	NULL
,	NULL
Marksbery	NULL
J	NULL
.	NULL

Neurosci	NULL
.	NULL

,	NULL
June	NULL
15	NULL
,	NULL
1998	NULL
,	NULL
18	NULL
(	NULL
12	NULL
)	NULL
:4451-4460	NULL
4459	NULL
WR	NULL
,	NULL
Butterfield	NULL
DA	NULL
(	NULL
1994	NULL
)	NULL
A	NULL
protein	NULL
kinase	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
inflammatory	NULL
cytokine	NULL
biosynthesis	NULL
.	NULL

Nature	NULL
372:739-746	NULL
.	NULL

Leong	NULL
SK	NULL
,	NULL
Ling	NULL
E-A	NULL
(	NULL
1992	NULL
)	NULL
Ameboid	NULL
and	NULL
ramified	NULL
microglia	NULL
:	NULL
their	NULL
interrelationship	NULL
and	NULL
response	NULL
to	NULL
brain	NULL
injury	NULL
.	NULL

Glia	NULL
7:39-47	NULL
.	NULL

Lorton	NULL
D	NULL
,	NULL
Kocsis	NULL
J-M	NULL
,	NULL
King	NULL
L	NULL
,	NULL
Madden	NULL
K	NULL
,	NULL
Brunden	NULL
KR	NULL
(	NULL
1996	NULL
)	NULL
B-amyloid	NULL
induces	NULL
increased	NULL
release	NULL
of	NULL
Interleukin1B	NULL
from	NULL
Lipopolysaccharide-activated	NULL
human	NULL
monocytes	NULL
J	NULL
Neuroimmunol	NULL
67:21-29	NULL
.	NULL

Masters	NULL
CL	NULL
,	NULL
Simms	NULL
G	NULL
,	NULL
weinman	NULL
NA	NULL
,	NULL
Multhaup	NULL
G	NULL
,	NULL
McDonald	NULL
BL	NULL
,	NULL
Beyreuther	NULL
K	NULL
(	NULL
1985	NULL
)	NULL
Amyloid	NULL
core	NULL
protein	NULL
in	NULL
Alzheimer	NULL
's	NULL
disease	NULL
and	NULL
Down	NULL
's	NULL
Syndrome	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
82:4245-4249	NULL
.	NULL

McDonald	NULL
DR	NULL
,	NULL
Brunden	NULL
KR	NULL
,	NULL
Landreth	NULL
GE	NULL
(	NULL
1997	NULL
)	NULL
Amyloid	NULL
fibrils	NULL
activate	NULL
tyrosine	NULL
kinase-dependent	NULL
signaling	NULL
and	NULL
superoxide	NULL
production	NULL
in	NULL
microglia	NULL
.	NULL

J	NULL
Neurosci	NULL
17:2284-2294	NULL
.	NULL

McGeer	NULL
PL	NULL
,	NULL
Akiyama	NULL
H	NULL
,	NULL
Itagaki	NULL
S	NULL
,	NULL
McGeer	NULL
EG	NULL
(	NULL
1989	NULL
)	NULL
Immune	NULL
system	NULL
response	NULL
in	NULL
Alzheimer	NULL
's	NULL
disease	NULL
.	NULL

Can	NULL
J	NULL
Neurol	NULL
Sci	NULL
16:516-527	NULL
.	NULL

McLaughlin	NULL
MM	NULL
,	NULL
Kumar	NULL
S	NULL
,	NULL
McDonnell	NULL
PC	NULL
,	NULL
Van	NULL
Horn	NULL
S	NULL
,	NULL
Lee	NULL
JC	NULL
,	NULL
Livi	NULL
GP	NULL
,	NULL
Young	NULL
PR	NULL
(	NULL
1996	NULL
)	NULL
Identification	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
(	NULL
MAP	NULL
)	NULL
kinase-activated	NULL
protein	NULL
kinase-3	NULL
,	NULL
a	NULL
novel	NULL
substrate	NULL
of	NULL
CSBP	NULL
p38	NULL
MAP	NULL
kinase	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
271:8488-8492	NULL
.	NULL

Meda	NULL
L	NULL
,	NULL
Cassatella	NULL
MA	NULL
,	NULL
Szendrei	NULL
GI	NULL
,	NULL
Otovos	NULL
L	NULL
,	NULL
Baron	NULL
P	NULL
,	NULL
Villalba	NULL
M	NULL
,	NULL
Ferrari	NULL
D	NULL
,	NULL
Rossi	NULL
F	NULL
(	NULL
1995	NULL
)	NULL
Activation	NULL
of	NULL
microglial	NULL
cells	NULL
by	NULL
B-amyloid	NULL
protein	NULL
and	NULL
interferon	NULL
y	NULL
.	NULL

Nature	NULL
374:647-650	NULL
.	NULL

Ohgami	NULL
T	NULL
,	NULL
Kitamoto	NULL
T	NULL
,	NULL
Shin	NULL
R-W	NULL
,	NULL
Kaneko	NULL
Y	NULL
,	NULL
Ogomori	NULL
K	NULL
,	NULL
Tateishi	NULL
J	NULL
(	NULL
1991	NULL
)	NULL
Increased	NULL
senile	NULL
plaques	NULL
with	NULL
microglia	NULL
in	NULL
Alzheimer	NULL
's	NULL
disease	NULL
.	NULL

Acta	NULL
Neuropathol	NULL
81:242-247	NULL
.	NULL

Oliver	NULL
JM	NULL
,	NULL
Burg	NULL
DL	NULL
,	NULL
Wilson	NULL
BS	NULL
,	NULL
McLaughlin	NULL
JM	NULL
,	NULL
Geahlen	NULL
RL	NULL
(	NULL
1994	NULL
)	NULL
Inhibition	NULL
of	NULL
mast	NULL
cell	NULL
Fc	NULL
epsilon	NULL
R1-mediated	NULL
signaling	NULL
and	NULL
effector	NULL
function	NULL
by	NULL
the	NULL
Syk	NULL
selective	NULL
inhibitor	NULL
,	NULL
piceatannol	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
269:29697-29703	NULL
.	NULL

Palkama	NULL
T	NULL
(	NULL
1991	NULL
)	NULL
Induction	NULL
of	NULL
interleukin-1	NULL
production	NULL
by	NULL
ligands	NULL
binding	NULL
to	NULL
the	NULL
scavenger	NULL
receptor	NULL
in	NULL
human	NULL
monocytes	NULL
and	NULL
the	NULL
THP1	NULL
cell	NULL
line	NULL
.	NULL

Immunology	NULL
74:432-438	NULL
.	NULL

Paresce	NULL
DM	NULL
,	NULL
Ghosh	NULL
RN	NULL
,	NULL
Maxfield	NULL
FR	NULL
(	NULL
1996	NULL
)	NULL
Microglial	NULL
cells	NULL
internalized	NULL
aggregates	NULL
of	NULL
the	NULL
Alzheimer	NULL
's	NULL
disease	NULL
amyloid	NULL
B-protein	NULL
via	NULL
a	NULL
scavenger	NULL
receptor	NULL
.	NULL

Neuron	NULL
17:553-565	NULL
.	NULL

Pelech	NULL
SL	NULL
,	NULL
Krebs	NULL
EG	NULL
(	NULL
1987	NULL
)	NULL
Mitogen-activated	NULL
S6	NULL
kinase	NULL
is	NULL
stimulated	NULL
via	NULL
protein	NULL
kinase	NULL
C-dependent	NULL
and	NULL
independent	NULL
pathways	NULL
in	NULL
Swiss	NULL
3T3	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
262:11598-11606	NULL
.	NULL

Pombo	NULL
CM	NULL
,	NULL
Bonventre	NULL
JV	NULL
,	NULL
Avurch	NULL
J	NULL
,	NULL
Woodgett	NULL
JR	NULL
,	NULL
Kyriakis	NULL
JM	NULL
,	NULL
Force	NULL
T	NULL
(	NULL
1994	NULL
)	NULL
The	NULL
stress-activated	NULL
protein	NULL
kinases	NULL
are	NULL
major	NULL
c-Jun	NULL
amino-terminal	NULL
kinases	NULL
activated	NULL
by	NULL
ischemia	NULL
and	NULL
reperfusion	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
269:26546-26551	NULL
.	NULL

Pulverer	NULL
B	NULL
,	NULL
Kyriakis	NULL
J	NULL
,	NULL
Avuruch	NULL
J	NULL
,	NULL
Nikolakaki	NULL
E	NULL
,	NULL
Woodget	NULL
J	NULL
(	NULL
1991	NULL
)	NULL
Phosphorylation	NULL
of	NULL
c-jun	NULL
mediated	NULL
by	NULL
MAP	NULL
kinases	NULL
.	NULL

Nature	NULL
353:760-674	NULL
.	NULL

Raingeaud	NULL
J	NULL
,	NULL
Gupta	NULL
S	NULL
,	NULL
Rogers	NULL
JS	NULL
,	NULL
Dickens	NULL
M	NULL
,	NULL
Han	NULL
J	NULL
,	NULL
Ulevitch	NULL
RJ	NULL
,	NULL
Davis	NULL
RJ	NULL
(	NULL
1995	NULL
)	NULL
Pro-inflammatory	NULL
cytokines	NULL
and	NULL
environmental	NULL
stress	NULL
cause	NULL
p38	NULL
Mitogen-activated	NULL
Protein	NULL
kinase	NULL
activation	NULL
by	NULL
dual	NULL
phosphorylation	NULL
on	NULL
tyrosine	NULL
and	NULL
threonine	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:7420-7426	NULL
.	NULL

Rouse	NULL
J	NULL
,	NULL
Cohen	NULL
P	NULL
,	NULL
Trigon	NULL
S	NULL
,	NULL
Morange	NULL
M	NULL
,	NULL
Alonso-Llamazares	NULL
A	NULL
,	NULL
Zamanillo	NULL
D	NULL
,	NULL
Hunt	NULL
T	NULL
,	NULL
Nebreda	NULL
AR	NULL
(	NULL
1994	NULL
)	NULL
A	NULL
novel	NULL
kinase	NULL
cascade	NULL
triggered	NULL
by	NULL
stress	NULL
and	NULL
heat	NULL
shock	NULL
that	NULL
stimulates	NULL
MAPKAP	NULL
kinase-2	NULL
and	NULL
phosphorylation	NULL
of	NULL
the	NULL
small	NULL
heat	NULL
shock	NULL
proteins	NULL
.	NULL

Cell	NULL
78:1027-1037	NULL
.	NULL

Selkoe	NULL
DJ	NULL
(	NULL
1996	NULL
)	NULL
Amyloid	NULL
B-Protein	NULL
and	NULL
the	NULL
Genetics	NULL
of	NULL
Alzheimer	NULL
's	NULL
Disease	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
271:18295-18298	NULL
.	NULL

Sheng	NULL
M	NULL
,	NULL
Thompson	NULL
MA	NULL
,	NULL
Greenberg	NULL
ME	NULL
(	NULL
1991	NULL
)	NULL
CREB	NULL
:	NULL
A	NULL
CaZ+-regulated	NULL
transcription	NULL
factor	NULL
phosphorylated	NULL
by	NULL
Calmodulin-dependent	NULL
kinases	NULL
.	NULL

Science	NULL
252:1427-1430	NULL
.	NULL

Simms	NULL
HH	NULL
,	NULL
Gaither	NULL
TA	NULL
,	NULL
Fries	NULL
LF	NULL
,	NULL
Frank	NULL
MM	NULL
(	NULL
1991	NULL
)	NULL
Monokines	NULL
released	NULL
during	NULL
short-term	NULL
Fc	NULL
gamma	NULL
receptor	NULL
phagocytosis	NULL
upregulate	NULL
polymorphonuclear	NULL
leukocytes	NULL
and	NULL
monocyte-phagocytic	NULL
function	NULL
.	NULL

J	NULL
Immunol	NULL
147:265-272	NULL
.	NULL

Smith	NULL
MA	NULL
,	NULL
Richey	NULL
Harris	NULL
PL	NULL
,	NULL
Sayre	NULL
LM	NULL
,	NULL
Beckman	NULL
JS	NULL
,	NULL
Perry	NULL
G	NULL
(	NULL
1997	NULL
)	NULL
Widespread	NULL
peroxynitrite-mediated	NULL
damage	NULL
in	NULL
Alzheimer	NULL
's	NULL
Disease	NULL
.	NULL

J	NULL
Neurosci	NULL
17:2653-2657	NULL
.	NULL

Stokoe	NULL
D	NULL
,	NULL
Campbell	NULL
DG	NULL
,	NULL
Nakielny	NULL
S	NULL
,	NULL
Hidaka	NULL
H	NULL
,	NULL
Leevers	NULL
SJ	NULL
,	NULL
Marshall	NULL
C	NULL
,	NULL
Cohen	NULL
P	NULL
(	NULL
1992a	NULL
)	NULL
MAPKAP	NULL
kinase-2	NULL
;	NULL
a	NULL
novel	NULL
protein	NULL
kinase	NULL
activated	NULL
by	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
.	NULL

EMBO	NULL
J	NULL
11:3985-3994	NULL
.	NULL

Stokoe	NULL
D	NULL
,	NULL
Engel	NULL
K	NULL
,	NULL
Campbell	NULL
DG	NULL
,	NULL
Cohen	NULL
P	NULL
,	NULL
Gaestel	NULL
M	NULL
(	NULL
1992b	NULL
)	NULL
Identification	NULL
of	NULL
MAPKAP	NULL
kinase-2	NULL
as	NULL
a	NULL
major	NULL
enzyme	NULL
responsible	NULL
for	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
small	NULL
heat	NULL
shock	NULL
proteins	NULL
FEBS	NULL
Lett	NULL
313:307-313	NULL
.	NULL

4460	NULL
J	NULL
.	NULL

Neurosci	NULL
.	NULL

,	NULL
June	NULL
15	NULL
,	NULL
1998	NULL
,	NULL
18	NULL
(	NULL
12	NULL
)	NULL
:4451-4460	NULL
Terzi	NULL
E	NULL
,	NULL
Holzemann	NULL
G	NULL
,	NULL
Seelig	NULL
J	NULL
(	NULL
1994	NULL
)	NULL
Reversible	NULL
random	NULL
coil-B-sheet	NULL
transition	NULL
of	NULL
the	NULL
Alzheimer	NULL
B-amyloid	NULL
fragment	NULL
(	NULL
25-35	NULL
)	NULL
.	NULL

Biochemistry	NULL
33:1345-1350	NULL
.	NULL

Walker	NULL
DG	NULL
,	NULL
Kim	NULL
SU	NULL
,	NULL
McGeer	NULL
PL	NULL
(	NULL
1995	NULL
)	NULL
Complement	NULL
and	NULL
cytokine	NULL
expression	NULL
in	NULL
cultured	NULL
microglia	NULL
derived	NULL
from	NULL
postmortem	NULL
human	NULL
brains	NULL
.	NULL

J	NULL
Neurosci	NULL
Res	NULL
40:478-493	NULL
.	NULL

Wang	NULL
XZ	NULL
,	NULL
Ron	NULL
D	NULL
(	NULL
1996	NULL
)	NULL
Stress-induced	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
CHOP	NULL
(	NULL
GADD153	NULL
)	NULL
by	NULL
p38	NULL
MAP	NULL
Kinase	NULL
.	NULL

Science	NULL
272:1347-1349	NULL
.	NULL

Xie	NULL
H	NULL
,	NULL
Rothstein	NULL
TL	NULL
(	NULL
1995	NULL
)	NULL
Protein	NULL
kinase	NULL
C	NULL
mediates	NULL
activation	NULL
of	NULL
nuclear	NULL
cAMP	NULL
response	NULL
element-binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
in	NULL
B	NULL
lymphocytes	NULL
stimulated	NULL
through	NULL
surface	NULL
Ig	NULL
.	NULL

J	NULL
Immunol	NULL
154:1717-1723	NULL
.	NULL

McDonald	NULL
et	NULL
al	NULL
.	NULL

e	NULL
AB-Stimulated	NULL
Activation	NULL
of	NULL
MAP	NULL
Kinases	NULL
in	NULL
Microglia	NULL
Xie	NULL
H	NULL
,	NULL
Wang	NULL
Z	NULL
,	NULL
Rothstein	NULL
TL	NULL
(	NULL
1996	NULL
)	NULL
Signaling	NULL
pathways	NULL
for	NULL
antigen	NULL
receptor-mediated	NULL
induction	NULL
of	NULL
transcription	NULL
factor	NULL
CREB	NULL
in	NULL
B	NULL
lym-phocytes	NULL
.	NULL

Cell	NULL
Immunol	NULL
169:264-270	NULL
.	NULL

Xing	NULL
J	NULL
,	NULL
Ginty	NULL
DD	NULL
,	NULL
Greenberg	NULL
ME	NULL
(	NULL
1996	NULL
)	NULL
Coupling	NULL
of	NULL
the	NULL
RAS-MAPK	NULL
pathway	NULL
to	NULL
gene	NULL
activation	NULL
by	NULL
RSK2	NULL
,	NULL
a	NULL
growth	NULL
factor-regulated	NULL
CREB	NULL
kinase	NULL
.	NULL

Science	NULL
273:959-962	NULL
.	NULL

Yan	NULL
SD	NULL
,	NULL
Chen	NULL
X	NULL
,	NULL
Fu	NULL
J	NULL
,	NULL
Chen	NULL
M	NULL
,	NULL
Zhu	NULL
H	NULL
,	NULL
Roher	NULL
A	NULL
,	NULL
Slattery	NULL
T	NULL
,	NULL
Zhao	NULL
L	NULL
,	NULL
Nagashima	NULL
M	NULL
,	NULL
Morser	NULL
J	NULL
,	NULL
Migheli	NULL
A	NULL
,	NULL
Nawroth	NULL
P	NULL
,	NULL
Stern	NULL
D	NULL
,	NULL
Schmidt	NULL
AM	NULL
(	NULL
1996	NULL
)	NULL
RAGE	NULL
and	NULL
amyloid-B	NULL
peptide	NULL
neurotoxicity	NULL
in	NULL
Alzheimer	NULL
's	NULL
disease	NULL
.	NULL

Nature	NULL
382:685-691	NULL
.	NULL

Yankner	NULL
BA	NULL
,	NULL
Duffy	NULL
LK	NULL
,	NULL
Kirschner	NULL
DA	NULL
(	NULL
1990	NULL
)	NULL
Neurotropic	NULL
and	NULL
neuro-toxic	NULL
of	NULL
amyloid	NULL
B	NULL
protein	NULL
:	NULL
reversal	NULL
by	NULL
tachykinin	NULL
neuropeptides	NULL
.	NULL

Science	NULL
250:279-282	NULL
.	NULL

